<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">59612</article-id><article-id pub-id-type="doi">10.7554/eLife.59612</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>NMDA receptors control development of somatosensory callosal axonal projections</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-191707"><name><surname>Zhou</surname><given-names>Jing</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2809-7097</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191708"><name><surname>Lin</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40604"><name><surname>Huynh</surname><given-names>Trung</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-124189"><name><surname>Noguchi</surname><given-names>Hirofumi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9779-4956</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54248"><name><surname>Bush</surname><given-names>Jeffrey O</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6053-8756</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-197338"><name><surname>Pleasure</surname><given-names>Samuel J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8599-1613</contrib-id><email>samuel.pleasure@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Neurology, University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Weill Institute for Neurosciences, University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Neurological Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution>Department of Cell and Tissue Biology, Program in Craniofacial Biology and Institute for Human Genetics, University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Programs in Neuroscience and Developmental Stem Cell Biology, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Kavli Institute for Fundamental Neuroscience</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mason</surname><given-names>Carol A</given-names></name><role>Reviewing Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution>Fred Hutchinson Cancer Research Center</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>04</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e59612</elocation-id><history><date date-type="received" iso-8601-date="2020-06-03"><day>03</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-22"><day>22</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Zhou et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Zhou et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-59612-v2.pdf"/><abstract><p>Callosal projections from primary somatosensory cortex (S1) are key for processing somatosensory inputs and integrating sensory-motor information. How the callosal innervation pattern in S1 is formed during early postnatal development is not clear. We found that the normal termination pattern of these callosal projections is disrupted in cortex specific NMDAR mutants. Rather than projecting selectively to the primary/secondary somatosensory cortex (S1/S2) border, axons were uniformly distributed throughout S1. In addition, the density of this projection increased over postnatal life until the mice died by P30. By combining genetic and antibody-mediated loss of function, we demonstrated that it is GluN2B-containing NMDA receptors in target S1 that mediate this guidance phenotype, thus playing a central role in interhemispheric connectivity. Furthermore, we found that this function of NMDA receptors in callosal circuit formation is independent of ion channel function and works with the EPHRIN-B/EPHB system. Thus, NMDAR in target S1 cortex regulates the formation callosal circuits perhaps by modulating EPH-dependent repulsion.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>axon guidance</kwd><kwd>corpus callosum</kwd><kwd>somatosensory cortex</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01MH119435</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Jing</given-names></name><name><surname>Lin</surname><given-names>Yong</given-names></name><name><surname>Huynh</surname><given-names>Trung</given-names></name><name><surname>Noguchi</surname><given-names>Hirofumi</given-names></name><name><surname>Pleasure</surname><given-names>Samuel J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01MH122471</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Jing</given-names></name><name><surname>Lin</surname><given-names>Yong</given-names></name><name><surname>Huynh</surname><given-names>Trung</given-names></name><name><surname>Noguchi</surname><given-names>Hirofumi</given-names></name><name><surname>Pleasure</surname><given-names>Samuel J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>R01DE023337</award-id><principal-award-recipient><name><surname>Bush</surname><given-names>Jeffrey O</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008069</institution-id><institution>University of California, San Francisco</institution></institution-wrap></funding-source><award-id>UCSF Weill Institute for Neurosciences Innovation Award</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Jing</given-names></name><name><surname>Lin</surname><given-names>Yong</given-names></name><name><surname>Huynh</surname><given-names>Trung</given-names></name><name><surname>Noguchi</surname><given-names>Hirofumi</given-names></name><name><surname>Pleasure</surname><given-names>Samuel J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008069</institution-id><institution>University of California, San Francisco</institution></institution-wrap></funding-source><award-id>UCSF Marcus Program in Precision Medicine Innovation Transformative Integrated Research Initiative</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Jing</given-names></name><name><surname>Lin</surname><given-names>Yong</given-names></name><name><surname>Huynh</surname><given-names>Trung</given-names></name><name><surname>Noguchi</surname><given-names>Hirofumi</given-names></name><name><surname>Pleasure</surname><given-names>Samuel J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>NMDAR receptors act in regulating axon guidance of somatosensory callosal projections in early postnatal life and the expression of EPHB2 receptors in target cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Synaptic connections between neurons form circuits that can convey neural information. Abnormalities at any stage of synaptic circuit development can result in neuropsychiatric pathology. The corpus callosum (CC) is the largest interhemispheric commissural circuit in mammals. The connectivity of the CC is essential for coordinated sensory-motor function and for many higher cognitive processes, and CC pathology is implicated in a variety of developmental disorders (<xref ref-type="bibr" rid="bib56">Paul, 2011</xref>).</p><p>Callosal projections originate from pyramidal neurons located in layers II/III, V, and VI and traverse the CC to form synapses with neurons in contralateral homotopic or heterotopic cortical areas. We previously showed (<xref ref-type="bibr" rid="bib81">Zhou et al., 2013</xref>) that the medial-lateral topography of callosal neurons in the cortex is tightly constrained by the dorsal-ventral (D-V) position of axons within the CC. The axon position within the CC determines its terminal location in the contralateral cortex, with dorsally located axons projecting medially and ventrally located axons projecting laterally. As such, the spatial organization of topographically represented information from one hemisphere is preserved as it is projected onto the contralateral hemisphere. However, the molecular determinants regulating proper targeting of commissural projections remain unknown.</p><p>In vivo Ca<sup>2+</sup> imaging and multiunit recordings show distinct patterns of neural activity in the cortex of newborn mice (<xref ref-type="bibr" rid="bib1">Adelsberger et al., 2005</xref>; <xref ref-type="bibr" rid="bib34">Khazipov and Luhmann, 2006</xref>; <xref ref-type="bibr" rid="bib33">Khazipov et al., 2004</xref>). These activity patterns synchronize spatially and temporally distinct neural networks and may play important roles in wiring cortical maps (<xref ref-type="bibr" rid="bib2">Allène et al., 2008</xref>; <xref ref-type="bibr" rid="bib18">Golshani et al., 2009</xref>; <xref ref-type="bibr" rid="bib79">Yang et al., 2009</xref>). Suppressing endogenous neural activity by overexpressing the inward rectifying potassium channel Kir2.1 in callosal neurons delays axon growth and results ultimately in layer-targeting defects in visual cortex and somatosensory cortex (<xref ref-type="bibr" rid="bib45">Mizuno et al., 2007</xref>; <xref ref-type="bibr" rid="bib62">Rodríguez-Tornos et al., 2016</xref>; <xref ref-type="bibr" rid="bib74">Wang et al., 2007</xref>). Sensory deprivation by ablating whiskers or transecting the infraorbital nerve (ION) before P5 blocks sensory activity to the trigeminal nerve and disrupts barrel field formation in primary somatosensory cortex (S1) with secondary disruption of callosal innervation at the S1/S2 border (<xref ref-type="bibr" rid="bib25">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Suárez et al., 2014</xref>). These studies show that directly reducing neural activity or blocking ascending sensory inputs to callosal neurons affects callosal targeting and map formation. However, the molecular mechanisms governing these events are not clear.</p><p>Neural activity is generally propagated from the axons of presynaptic neurons to the dendrites of postsynaptic neurons by the secretion of neurotransmitters. Neurotransmitter receptors located on the postsynaptic neuron regulate synaptic transmission. The NMDA receptor (NMDAR) is a glutamatergic neurotransmitter receptor located at the synapses that mediates the vast majority of excitatory neurotransmission in the cortex (<xref ref-type="bibr" rid="bib69">Traynelis et al., 2010</xref>). NMDAR mediated synaptic transmission is important in generating synchronized activity patterns in immature cortex, suggesting that NMDAR Ca<sup>2+</sup> channel may be involved in neural circuit formation.</p><p>In this study we examined the role of NMDAR in the formation of callosal circuitry. Initially, our hypothesis was that NMDARs would be important modulators of callosal circuit formation and that this would be mediated through the ion channel function by regulating neural activity. Indeed, we did find a crucial role for NMDAR in regulating callosal innervation patterns. To our surprise, this was not mediated by the ion channel function of NMDAR. Rather, there was a specific role for the GluN2B-containing NMDAR and loss of NMDAR resulted in changes in EPHB2 expression. EPHB2 is known to be necessary for localization of NMDAR to synapses (<xref ref-type="bibr" rid="bib52">Nolt et al., 2011</xref>); however, we found that this requirement was reciprocal – when NMDARs are lost, EPHB2 protein expression during development is lost as well. Most importantly, this is the first demonstration that interactions between NMDAR and EPHRIN-B/EPHB are required for neural circuit formation during development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Postnatal development of the S1 callosal projection</title><p>The development of commissural S1 projections serves as an ideal model to study interhemispheric circuit development. To understand normal development of the S1 callosal projection, we labeled the progenitor cells for layer II/III neurons with enhanced green fluorescent protein (EGFP) by in utero electroporation at embryonic day (E) 15.5 and examined callosal development at four critical time points (<xref ref-type="fig" rid="fig1">Figure 1</xref>). At postnatal day (P) 5, the callosal axons from S1 had reached the white matter underneath contralateral S1 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). At P8, the callosal axons were diffusely distributed in contralateral S1 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). By P12, pruning of excess projections led to a refined innervation pattern with a narrow band limited to the S1/S2 border (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). After P12, the pattern is generally stable, as shown at P30 (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The callosal somatosensory innervation pattern was disrupted in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice.</title><p>(<bold>A–E</bold>) Postnatal development of callosal projection in S1. (<bold>A</bold>) EGFP plasmid injected into lateral ventricle of embryo at embryonic day 15.5 (E15.5) and electrical pulse given to enable the plasmid to enter cortical progenitor cells of layer II/III in the ventricular zone. (<bold>B, B’</bold>) At postnatal day 5 (<bold>P5</bold>), the callosal axons from S1 had reached the white matter underneath contralateral S1. (<bold>C, C’</bold>) At P8, the callosal axons were diffusely distributed in contralateral S1. (<bold>D, D’</bold>) By P12, pruning of excess projections led to a refined innervation pattern with a narrow band limited to the S1/S2 border. (<bold>E, E’</bold>) After P12, the pattern was stable as observed at P30. (<bold>F</bold>) In P14 control mice (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/wt</sup></italic>), the callosal innervation pattern of S1 of the contralateral cortex is well differentiated with a dense innervation at S1/S2 border. The pattern persists to P30 (<bold>J</bold>). (<bold>G</bold>) In GluN1 KO mice (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic>), the innervation pattern was disrupted and projections were extremely diffused which also persisted to P30 (<bold>K</bold>). (<bold>H</bold>) Quantification of fluorescent intensity across the medial to lateral extent of the S1. (<bold>I, L</bold>) Quantification of fluorescence density of S1 region of control vs. GluN1 KO mice at P14 (<bold>I</bold>, p=0.002) and P30 (<bold>L</bold>, p=0.0003). Scale bar: 500 μm for all images. S1: primary somatosensory cortex; S2: secondary somatosensory cortex.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The expression of NMDAR in cortex was reduced in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice.</title><p>Examples of 12 µm coronal brain sections from P8 <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup></italic> (<bold>A</bold>) and <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> (<bold>B</bold>) of the same litter. Immunostaining of vesicular glutamate transporter 2 (VGult2) showed thalamocortical barrels in Layer IV of S1 which are pointed out by arrows. The VGlut2 staining in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup></italic> mice revealed a clear barrel pattern (<bold>Aa</bold>). However, the barrel pattern in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice was disrupted and less distinct (<bold>Ba</bold>). The GluN1 staining in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup></italic> mice were dense and strong in cortex (<bold>Ab</bold>, <bold>Ac</bold>). However, the staining in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice was less bright and apparently reduced in Layer V and VI (<bold>Bb</bold>, <bold>Bc</bold>). (<bold>C</bold>) Western blot of cortical protein extracts from P8 S1. Relative to the loading control GAPDH, the protein levels of GluN1 were greatly reduced in the four samples of <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice compared to the four samples of controls. (<bold>D</bold>) Quantification of protein levels of GluN1 relative to GAPDH. p=0.0002. Scale bar: 100 μm for <bold>Ac</bold> and <bold>Bc</bold>; 500 μm for rest of images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>GluN1 knock-out (KO) mice have disrupted callosal innervation</title><p>NMDARs are heteromeric receptor channel complexes that differ in subunit composition. To date, seven different subunits have been identified: the GluN1 subunit, four distinct NR2 subunits (A–D), and a pair of GluN3 subunits. The GluN1 subunit is the essential subunit of NMDARs (<xref ref-type="bibr" rid="bib10">Dingledine et al., 1999</xref>; <xref ref-type="bibr" rid="bib55">Paoletti et al., 2013</xref>). Global GluN1 knockout mice die within a few hours of birth (<xref ref-type="bibr" rid="bib16">Forrest et al., 1994</xref>). To explore the role of NMDAR in callosal development, we generated cortex-specific GluN1 knock-out (KO) mice by crossing a floxed GluN1 allele mice (<italic>Grin1<sup>fl/fl</sup></italic>) with Emx1-Cre recombinase (Cre) mice (<italic>Emx1<sup>cre/+</sup></italic>) thereby selectively deleting GluN1 in excitatory cortical projection neurons. Since GluN1 is essential, GluN1 deletion results in loss of functional NMDARs in cortical excitatory neurons. Immunostaining and western blot at P8 showed that expression of cortical GluN1 was greatly diminished (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) in GluN1 KO mice. Consistent with previous studies (<xref ref-type="bibr" rid="bib29">Iwasato et al., 2000</xref>; <xref ref-type="bibr" rid="bib39">Lo et al., 2013</xref>), the organization of thalamocortical barrels in Layer IV of S1 was somewhat disrupted but still apparent in GluN1 KO mice at P8, as revealed by vesicular glutamate transporter 2 (VGlut2) immunostaining (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>To investigate whether NMDAR plays a role in the targeting of callosal projections to contralateral cortex, we first examined the callosal innervation pattern at P14, by which point the mature pattern has formed. In littermate controls (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/wt</sup></italic>), a dense area of innervation was formed at the S1/S2 border (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) and the overall pattern was the same as wild-type controls in <xref ref-type="fig" rid="fig1">Figure 1D</xref>. However, in GluN1 KO mice (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice), the normal restricted pattern of callosal targeting to the S1/S2 border was absent, and callosal axons were uniformly distributed throughout the contralateral somatosensory cortex (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Quantitative fluorescence intensity analysis showed that the axon distribution pattern in S1 was statistically significantly different between littermate control and GluN1 KO mice (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Additionally, fluorescence density analysis showed that GluN1 KO mice also had more overall callosal axons innervating S1 at P14 (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). This result suggests that the NMDAR plays a role in callosal circuit formation. In the absence of NMDAR, the targeted callosal innervation of the S1/S2 border was lost, and the overall callosal innervation in S1 was significantly increased. GluN1 KO mice were smaller than littermate controls after P5 (data not shown) and rarely survived past P30 so we chose P30 as the last time point to determine if this defect persists. We found that this phenotype worsens after P14 (<xref ref-type="fig" rid="fig1">Figure 1J–L</xref>).</p></sec><sec id="s2-3"><title>GluN1 KO mice prematurely innervate S1</title><p>To determine when this prominent targeting defect can first be detected, we examined different time points (P0, P3, P5, and P6) corresponding to critical phases of initial CC circuit formation – initial axon extension to ipsilateral CC (P0), axons crossing the midline (P3), axons reaching the white matter underneath contralateral S1 (P5), and axons starting to innervate S1 (P6). GluN1 KO mice showed no differences with littermate controls at P0, P3, and P5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) indicating no difference in the overall rate of axon growth. However, GluN1 KO mice showed earlier and increased innervation of S1 at P6, when callosal axons start entering the contralateral cortex (<xref ref-type="fig" rid="fig2">Figure 2B and E</xref>). In control littermates, at P6, callosal axons were gathered into a bundle under contralateral S1 with few axons penetrating into S1. The penetrating axons in S1 were distributed across layer VI (‘*’ in S1 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>), and layer V (arrows in S1 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>) but failed to penetrate to more superficial layers. In contrast, axons targeting S1 in GluN1 KO mice at P6 had extended past layer V, with many axons terminating in layer II/III (arrows in S1 in <xref ref-type="fig" rid="fig2">Figure 2B</xref>). Interestingly, while control mice showed equal degrees of callosal innervation from medial to lateral S1 (see arrows in S1 in <xref ref-type="fig" rid="fig2">Figure 2A</xref>), GluN1 KO mice showed preferential early callosal innervation of medial S1 (see arrows in S1 in <xref ref-type="fig" rid="fig2">Figure 2B</xref>), and this was even more apparent at P8 (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The callosal innervation defect was first detected at P6 in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice.</title><p>(<bold>A, A’</bold>) At P6, most axons in control grew into deeper layer VI of S1 (see ‘*’); a few axons grew to layer V from medial to lateral S1 (see arrows). However, axons projecting to lateral S2 had grown to layer IV which was apparently faster than the axons in S1 (see arrows). (<bold>B, B’</bold>) In GluN1 KO mice, most axons had grown to layer V and some even grew to layer I (see arrows) at P6. (<bold>C, D</bold>) At P8, axons in control and mutant mice had grown to the superficial layer of cortex. However, the innervation patterns were different. Controls showed more axon innervation in the lateral S1 with dense callosal innervation at S1/S2 border (<bold>C</bold>). Mutants showed slightly more axon innervation in the medial S1 (<bold>D</bold>). (<bold>E</bold>) The fluorescence density of mutant mice in S1 was significantly higher than in control mice at P6 which suggested that the mutants had increased axon innervation in contralateral S1 at P6. p=0.003. Scale bar: 500 μm for all images. The square brackets in all images outline the S1. The arrow heads in all images outline the S1/S2 border. White lines outline different layers in the cortex of <bold>A–D</bold>. M: medial; L: lateral.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>There was no difference between <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/wt</sup></italic> and <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice during axonal extension into the ipsilateral CC (<bold>P0</bold>) and to the contralateral CC (<bold>P5</bold>).</title><p>(<bold>A, B</bold>) The callosal axons in S1 formed a bundle and grew into the ipsilateral CC at P0 in control and GluN1 KO littermates (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/wt</sup></italic> and <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice). The arrows show the extent of axon growth into the CC. By P3, the callosal axons crossed the midline (<bold>C, D</bold>) and by P5, the callosal axons have grown to underneath the contralateral S1 (<bold>E, F</bold>). Scale bar: 500 μm for all images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>No increased cell death in S1 of <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice at P6.</title><p>(<bold>A</bold>) In control mice (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/wt</sup></italic>), cleaved caspase-3<sup>+</sup> cells were mostly detected in layer II/III of M1 (<bold>A’</bold>), only rare cell death was observed in other cortical regions, such as S1 (<bold>A’’</bold>). (<bold>B</bold>) Compared with controls, there was increased cell death in layer II/III of motor cortex in mutant mice (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic>) (<bold>B’</bold>). However, compared with controls, there was no increased cell death in other cortical regions in mutant mice, such as S1 (<bold>B’’</bold>). Scale bar: 500 μm for <bold>A</bold> and <bold>B</bold>; 200 μm for <bold>A’</bold>, <bold>A’’</bold>, <bold>B’</bold>, and <bold>B’’</bold>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Callosal axon density analysis by Image J.</title><p>(<bold>A</bold>) This picture was an 8-bit image. (<bold>B</bold>) Fluorescence signals within threshold in image <bold>A</bold> turned to red after setting up threshold range. Box I was drawn to encompass only the S1. Box II was used to measure axon density in the midline.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig2-figsupp3-v2.tif"/></fig></fig-group><p>Because this defect was first detected at P6, we wondered whether increased cell death of target cortical neurons could account for the mis-innervation of S1. We used active (cleaved) caspase-3 as a marker of cell death in control and GluN1 KO mice at P6. In control mice, cleaved caspase-3<sup>+</sup> cells were mostly detected in layer II/III of primary motor cortex (M1), and rarely were observed in other cortical regions (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). Mutants did have increased cell death in layer II/III of M1 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>’); however, there was no increase in cell death in other cortical regions including S1 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>’’).</p><p>Taken together, these data indicate that the deletion of NMDAR in excitatory cortical neurons leads to premature and disrupted callosal innervation of contralateral S1. Furthermore, this excessive innervation persists and is not corrected by pruning of mistargeted axons at later developmental stages.</p></sec><sec id="s2-4"><title>The NMDAR is required in target neurons for normal callosal innervation</title><p>In GluN1 KO mice, the NMDAR is deleted from both projecting (presynaptic) and target (postsynaptic) neurons. To examine the role of NMDAR in presynaptic projecting callosal neurons, we electroporated vectors encoding Cre and EGFP into S1 of homozygous floxed GluN1 mice at E15.5 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Compared with littermate controls (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), presynaptic deletion of GluN1 (ipsiS1-/-) from neurons had no discernible effect on callosal innervation at P14 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This suggests that NMDAR is not required for projecting neurons to properly target S1. To determine whether GluN1 is required in the S1 target neurons, we deleted NMDAR in contralateral target neurons by in utero electroporation. To delete NMDAR in all cortical layers of the contralateral cortex, a Cre vector was electroporated into <italic>Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice in the contralateral/target S1 at E12.5 followed by a second electroporation of EGFP on E15.5 to label ipsilateral/projecting S1 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). <italic>Rosa26<sup>fs-tdTomato</sup></italic> mice express the fluorescent protein tdTomato after Cre-mediated recombination, and therefore labeled cells where Cre-mediated excision occurred and thus GluN1 should be deleted (<xref ref-type="bibr" rid="bib42">Madisen et al., 2010</xref>). Control mice (<italic>Grin1<sup>wt/wt</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice) after double electroporation were analyzed at P14 (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) and showed no defects. However, selective deletion of postsynaptic GluN1 in experimental mice strikingly increased callosal S1 innervation (<xref ref-type="fig" rid="fig3">Figure 3G and H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) similar to the deletion of GluN1 in all excitatory cortical neurons (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). These results suggest that NMDAR is required in the target neurons only for normal callosal circuit formation.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>NMDAR is required in target neurons for normal callosal innervation.</title><p>(<bold>A–D</bold>) Deleting NMDAR specifically in projecting neurons. Vectors expressing Cre-recombinase (Cre) and EGFP were delivered into S1 of floxed GluN1 mice (<italic>Grin1<sup>fl/wt</sup></italic> x <italic>Grin1<sup>fl/wt</sup></italic>) by in utero electroporation at E15.5 (<bold>A</bold>). Callosal innervation patterns at P14 in control <italic>Grin1<sup>+/+</sup></italic> mice (<bold>B</bold>) and mice after ipsilateral deletion (<bold>C</bold>). (<bold>D</bold>) Quantification of fluorescence density. p=0.317. (<bold>E–H</bold>) Deleting NMDAR specifically in target neurons. GluN1 was deleted in target contralateral S1 by in utero electroporation of Cre at E12.5 in <italic>Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice, the ipsilateral projecting neurons were labeled by EGFP at E15.5 (<bold>E</bold>). Compared with control <italic>Grin1<sup>wt/wt</sup>; Rosa26<sup>fs-tdTomato</sup></italic> (<bold>F</bold>), <italic>Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice which specifically deleted GluN1 in target S1 showed increased callosal innervation in S1 as ‘*’ shows (<bold>G</bold>). (<bold>H</bold>) Quantification of fluorescence density. p=0.002. Scale bar: 500 μm for all images. <italic>R26<sup>tdT</sup>: Rosa26<sup>fs-tdTomato</sup>.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Deleting NMDAR specifically in target neurons.</title><p>GluN1 was deleted in target contralateral S1 by in utero electroporation of Cre at E12.5 in <italic>Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice, the ipsilateral projecting neurons were labeled by EGFP at E15.5. This figure shows images from all of the animals that were analyzed for the statistical analysis. Scale bar: 500 μm for all images. <italic>R26<sup>tdT</sup>: Rosa26<sup>fs-tdTomato</sup>.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Increased callosal innervation in S1 after contralateral injection of anti-NMDAR antibodies</title><p>NMDAR antibodies directed to an extracellular domain of GluN1 are known to downregulate the numbers of surface NMDARs. To further examine that it is the contralateral/target expression of NMDAR in deep cortical layers is required for callosal axon targeting, we decided to use infusions of anti-GluN1 antibodies to block NMDAR function and expression in a temporally specific manner. We chose a commercial antibody against the amino acid residues 385–399 in the extracellular N-terminal domain of GluN1. It has been shown that this antibody can alter the surface distribution and dynamics of NMDAR (<xref ref-type="bibr" rid="bib12">Dupuis et al., 2014</xref>). To examine the efficiency of injection and whether the injection itself can cause brain damage, we injected the anti-GluN1 antibodies into the lateral ventricle from P2 to P8 and perfused the mice 3 hr after the last injection. The distribution of anti-GluN1 antibodies was most abundant in deep cortical layers of the ipsilateral injected hemisphere (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Thus, presumably due to the widespread high level of expression of GluN1, the antibodies are not distributed widely in the cortex, but rather remain predominantly on the side of injection.</p><p>Next, we injected the anti-GluN1 antibodies into the lateral ventricle from P2 to P12 either ipsilateral or contralateral to the origin of EGFP labeled callosal neurons and examined callosal innervation patterns at P14. The fluorescence density analysis at P14 showed that the contralateral (<xref ref-type="fig" rid="fig4">Figure 4E–H</xref>) but not ipsilateral antibody injections (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>) led to more overall callosal innervation in S1 at P14. This further supports our genetic data that contralateral/target expression of NMDAR in deep cortical layers is required for callosal axon targeting.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Increased callosal innervation in S1 after contralateral but not ipsilateral injection of anti-NMDAR antibodies from P2 to P12.</title><p>(<bold>A–D</bold>) Anti-GluN1 antibodies were injected into the lateral ventricle from P2 to P12 in ipsilateral cortex. RbIgG served as control. Compared with control (<bold>B</bold>), antibody injection in mice did not show increased callosal innervation in S1 at P14 (<bold>C</bold>). (<bold>D</bold>) Quantification of fluorescence density. p=0.94. (<bold>E–H</bold>) Anti-GluN1 antibodies were injected into the lateral ventricle from P2 to P12 in contralateral cortex. Compared with control (<bold>F</bold>), antibody injection in mice showed increased callosal innervation in S1 at P14 (see ‘*', <bold>G</bold>). (<bold>H</bold>) Quantification of fluorescence density. p=0.0002. Scale bar: 500 μm for all images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The efficiency of intraventricular antibody injection and the distribution territory in the cortex after 3 hr of last injection.</title><p>(<bold>A</bold>) Anti-GluN1 antibodies were injected into the lateral ventricle from P2 to P8 and mice were perfused 3 hr later after last injection. Rabbit IgG served as control. Mouse brains then were stained with anti-Rabbit secondary coupled with Alexa594. The red fluorophore of Alexa594 indicated where the antibodies had distributed to. Scale bar: 500 μm for all images. (<bold>B, B’</bold>) In control, the fluorescence signals were mostly detected in the cortex of the ipsilateral injection side, and few in the contralateral cortex. In the ipsilateral injection side, the signals were detected in all the cortical layers, but most strongly in the pia, layer I, layer V, layer VI, cingulum, and corpus callosum (see arrows). The signals were also detected in the hippocampus and contralateral motor cortex (see arrows). (<bold>C, C’</bold>) The general antibody distribution pattern was similar as seen in control. Moreover, the anti-GluN1 antibody can bind to NMDAR on the cell membranes, which thus showing beautiful cell membrane staining (see arrows in <bold>C’</bold>). Scale bar: 500 μm for <bold>B</bold>, <bold>C</bold>; 200 μm for <bold>B’</bold>, <bold>C’</bold>. CC: corpus callosum; cg: cingulum; Hip: hippocampus; M: motor cortex; S1: primary somatosensory cortex; S2: secondary somatosensory cortex.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig4-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>NMDAR are required specifically during callosal axon growth into contralateral S1</title><p>The antibody injections from P2 to P12 cover all the critical postnatal phases of CC development – (a) axons crossing midline (P3); (b) axons reaching the CC underneath contralateral S1 (P5); (c) growth into S1 (P6–P8); and (d) the refinement of projections (P8–P12). Thus, it is difficult to be certain when during this time the antibodies are acting to cause the observed increased callosal innervation. Our genetic data indicates the role of NMDAR in callosal development is first seen during the process of callosal axon growth into S1. However, the callosal innervation pattern in S1 does not only include the process of projecting into S1 but also the later refinement of projection. To address the temporal role of NMDAR in callosal development, we injected antibodies either from P4 to P8 or from P8 to P14 and examined the callosal innervation pattern at P14. We found that antibody injections from P4 to P8 had increased callosal axonal growth into S1 similar to that observed in NMDAR genetic deletion mice (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>). However, antibody injections only from P8 to P14 had no effect on the overall callosal innervation pattern and we saw no increased callosal innervation in S1 (<xref ref-type="fig" rid="fig5">Figure 5E–H</xref>). As mentioned before, the GluN1 KO mice showed earlier and increased innervation of S1 when the callosal axons started entering target cortex at P6 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), but there was no difference between GluN1 KO and littermate controls before P6 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Thus, taking the genetic and antibody injection data together suggests that the crucial effect of NMDAR on callosal circuit formation is primarily during callosal projection into the cortex (P6–P8).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Contralateral injection of anti-NMDAR antibodies from P4 to P8 but not P8 to P14 had increased callosal innervation in S1.</title><p>(<bold>A–D</bold>) Anti-GluN1 antibodies were injected into the lateral ventricle from P4 to P8 in contralateral cortex. RbIgG served as control. Compared with control (<bold>B</bold>), antibody injection in mice show increased callosal innervation in S1 at P14 (<bold>C</bold>). (<bold>D</bold>) Quantification of fluorescence density. p=0.004. (<bold>E–H</bold>) Anti-GluN1 antibodies were injected into the lateral ventricle from P8 to P14 in contralateral cortex. Compared with control (<bold>F</bold>), antibody injection in mice did not show increased callosal innervation in S1 at P14 (<bold>G</bold>). (<bold>H</bold>) Quantification of fluorescence density. p=0.69. Scale bar: 500 μm for all images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig5-v2.tif"/></fig></sec><sec id="s2-7"><title>GluN2B, but not GluN2A, is required for callosal axon targeting</title><p>GluN1 is an obligatory component of tetrameric NMDA receptors and is required for assembly of functional NMDAR. Therefore, NMDARs were entirely absent from excitatory cortical projection neurons in our GluN1 KO mice. In the forebrain, GluN1 primarily assembles with GluN2A and GluN2B to form functional NMDARs. GluN2A- and GluN2B-containing NMDARs are functionally distinct (<xref ref-type="bibr" rid="bib36">Kutsuwada et al., 1992</xref>; <xref ref-type="bibr" rid="bib40">Loftis and Janowsky, 2003</xref>) and follow different developmental expression trajectories with GluN2B as the major NR2 subunit during the first postnatal week and GluN2A expression present but increasing thereafter (<xref ref-type="bibr" rid="bib38">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="bib46">Monyer et al., 1994</xref>; <xref ref-type="bibr" rid="bib64">Sans et al., 2000</xref>; <xref ref-type="bibr" rid="bib66">Sheng et al., 1994</xref>). We wondered whether GluN2A-containing or GluN2B-containing NMDARs play different roles in S1 callosal development. Thus, we crossed <italic>Emx1</italic><sup>cre/+</sup> mice with <italic>Grin2a<sup>fl/fl</sup></italic> mice (GluN2A KO) and <italic>Grin2b<sup>fl/fl</sup></italic> mice (GluN2B KO) (<xref ref-type="bibr" rid="bib19">Gray et al., 2011</xref>). To address previous studies that found that GluN2A was expressed at lower levels during development, we checked the expression of GluN2A in S1 at P8 and found that it was dramatically diminished in <italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/fl</sup></italic> mice (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A and B</xref>), while the expression of GluN2B was the same in control and <italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/fl</sup></italic> mice (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A and C</xref>), and similarly GluN2A expression was unchanged in <italic>Emx1<sup>cre/+</sup>; Grin2b<sup>fl/fl</sup></italic> mice (<bold>data not shown</bold>).</p><p>In GluN2A KO mice, the overall callosal innervation pattern was similar to control mice, although there was increased callosal innervation at the M1/S1 border at P14 (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>). The body size of GluN2A KO mice was not significantly different from littermate controls, and they survived to adulthood. At P30, the general callosal innervation pattern of GluN2A KO mice was similar to littermate controls; however, the increased callosal innervation at the M1/S1 border persisted (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–C</xref>). In contrast, GluN2B deletion phenocopied GluN1 deletion with increased S1 innervation and loss of targeted innervation of the S1/S2 border at P14 (<xref ref-type="fig" rid="fig6">Figure 6D–F</xref>). Similar to GluN1 KO mice, GluN2B KO mice were smaller than littermate controls after P5 and rarely survived past P30. Like GluN1 KO mice, this phenotype continued to worsen after P14 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D–F</xref>). Either GluN2A-containing or GluN2B-containing NMDAR is channel competent and GluN2A-containing NMDARs are present in the cortex of GluN2B KO mice, thus it seems possible that NMDAR’s role in callosal circuit development may be separable from its channel activity.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2b<sup>fl/fl</sup></italic> but not <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2a<sup>fl/fl</sup></italic> mice had the same disrupted callosal innervation patterns as <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> at P14.</title><p>Callosal innervation patterns in control <italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/wt</sup></italic> (<bold>A</bold>) and <italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/fl</sup></italic> mice (<bold>B</bold>) at P14. ‘*’ points out M1/S1 border. (<bold>C</bold>) Quantification of fluorescence density. p=0.392. Callosal innervation patterns in control <italic>Emx1<sup>cre/+</sup>; Grin2b<sup>fl/wt</sup></italic> (<bold>D</bold>) and <italic>Emx1<sup>cre/+</sup>; Grin2b<sup>fl/fl</sup></italic> mice (<bold>E</bold>) at P14. (<bold>F</bold>) Quantification of fluorescence density. p=0.03. Scale bar: 500 μm for all images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>NR2B (<italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2b<sup>fl/fl</sup></italic>) but not NR2A (<italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2a<sup>fl/fl</sup></italic>) mice had same disrupted callosal innervation patterns as <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> at P30.</title><p>(<bold>A</bold>) The callosal innervation pattern in S1 at P30 in control mice (<italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/wt</sup></italic>) is similar as the pattern in P14 WT control mice, with few axons in S1 but a dense innervation at S1/S2 border. (<bold>B</bold>) In the mutant mice (<italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/fl</sup></italic>), the general innervation pattern was as same as control. However, the increased callosal innervation at the border of M1 and S1 was persistent at P30 (see ‘*’ in <bold>B’</bold>). (<bold>C</bold>) Quantification of fluorescence density. p=0.63. (<bold>D</bold>) In control <italic>Emx1<sup>cre/+</sup>; Grin2b<sup>fl/wt</sup></italic> mice, the callosal innervation pattern at P30 was as normal as WT control. (<bold>E</bold>) However, the increased callosal innervation in <italic>Emx1<sup>cre/+</sup>; Grin2b</italic><sup>fl/fl</sup> mice lasted at least to P30 as we observed in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice at P30. (<bold>F</bold>) Quantification of fluorescence density. p=0.007. Scale bar: 500 μm for all images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>The protein expression level of GluN2A and GluN2B in S1 at P8.</title><p>(<bold>A</bold>) Western blot analysis of cortical protein extracts from P8 S1 showed that GluN2A protein has been expressed in S1 at P8. Relative to the loading control GAPDH, the protein levels of GluN2A were greatly reduced in the five samples of <italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/fl</sup></italic> mice compared to the five samples of controls. However, the protein levels of GluN2B were same between the five samples of <italic>Emx1<sup>cre/+</sup>; Grin2a<sup>fl/fl</sup></italic> mice and the five samples of controls. (<bold>B</bold>) Quantification of protein levels of GluN2A relative to GAPDH. p=0.007. (<bold>C</bold>) Quantification of protein levels of GluN2B relative to GAPDH. p=0.5.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig6-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-8"><title>NMDAR regulates callosal circuit development independent of NMDAR channel activity</title><p>Ca<sup>2+</sup> influx through NMDARs is essential for synaptogenesis, experience-dependent synaptic remodeling, and long-lasting changes in synaptic efficacy such as long-term potentiation (LTP) and long-term depression (LTD) (<xref ref-type="bibr" rid="bib5">Collingridge et al., 2004</xref>; <xref ref-type="bibr" rid="bib37">Lau and Zukin, 2007</xref>). However, accumulating evidence shows that there are NMDAR functions independent of its ion-influx (<xref ref-type="bibr" rid="bib32">Kessels et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Nabavi et al., 2013</xref>), such as a use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux (<xref ref-type="bibr" rid="bib72">Vissel et al., 2001</xref>), and NMDAR-dependent LTD which can be induced independent of Ca<sup>2+</sup> influx (<xref ref-type="bibr" rid="bib11">Dore et al., 2016</xref>). In models of ischemic stroke, neuronal death caused by overactivation of NMDAR is also independent of Ca<sup>2+</sup> influx, but dependent on signaling complexes formed by NMDARs, Src kinase, and Panx1 (<xref ref-type="bibr" rid="bib75">Weilinger et al., 2016</xref>). To address whether channel activity of the NMDAR is required in callosal targeting, we systemically injected MK-801, a non-competitive NMDAR antagonist during CC development. MK-801 enters the open NMDAR channel and binds to the ‘blocking site’ located deep in the pore, blocking Ca<sup>2+</sup> influx through NMDAR (<xref ref-type="bibr" rid="bib26">Huettner and Bean, 1988</xref>, <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Based on previous literature, a single dose of MK-801 for acute i.p. administration is up to 1–10 mg/kg (<xref ref-type="bibr" rid="bib17">Foster et al., 1988</xref>; <xref ref-type="bibr" rid="bib44">Mitrovic et al., 1996</xref>); the daily dose of MK-801 for chronic i.p. administration is around 0.3–0.6 mg/kg (<xref ref-type="bibr" rid="bib51">Nilsson et al., 1997</xref>; <xref ref-type="bibr" rid="bib70">Uttl et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Zuo et al., 2006</xref>). Previous studies showed that blocking NMDAR with a daily dose of 0.4 mg/kg MK-801 in ferret pups between P14 and P21 disrupted axonal pattern formation by retinal afferents in the lateral geniculate nucleus (LGN) (<xref ref-type="bibr" rid="bib21">Hahm et al., 1999</xref>). We identified a dose of 1 mg/kg MK-801 (see Materials and methods for detail) to block Ca<sup>2+</sup> influx of NMDAR from P4 to P12 and examined the callosal innervation pattern at P14 (<xref ref-type="fig" rid="fig7">Figure 7A–D</xref>). Compared with saline control, MK801-treated pups gained weight slowly and developed opisthotonic posturing of limbs and head (data not shown), suggesting the channel function of NMDAR had been blocked. However, the normal callosal innervation pattern in these pups was similar to saline-treated controls (<xref ref-type="fig" rid="fig7">Figure 7B–D</xref>). Similar weight loss and abnormal behaviors have been reported in neonatal mice after MK-801 administration previously (<xref ref-type="bibr" rid="bib13">Facchinetti et al., 1993</xref>; <xref ref-type="bibr" rid="bib20">Griesbach and Amsel, 1998</xref>; <xref ref-type="bibr" rid="bib76">Wu et al., 2005</xref>). We also performed similar experiments using D(-)−2-amino-5-phosphonopentanoic acid (D-APV), which competitively blocks the ligand (glutamate) binding site to NMDAR and inhibits channel opening, thereby preventing Ca<sup>2+</sup> influx (<xref ref-type="bibr" rid="bib47">Morris, 1989</xref>, <xref ref-type="fig" rid="fig7">Figure 7E</xref>). In a previous study, a one-time infusion of 5 μg D-APV into the basolateral amygdala of adult rat (~250 g) caused memory deficit persistent for at least 4 weeks (<xref ref-type="bibr" rid="bib43">Milton et al., 2008</xref>). Also, blocking NMDARs by intracerebral infusion of 0.05 μg D-APV into P7 mouse pup reduced somatic calcium transients in pyramidal cells evoked by lateral olfactory tract stimulation, and caused memory deficits both in short-term (3 hr) and long-term (24 hr) odor preference memory (<xref ref-type="bibr" rid="bib48">Mukherjee and Yuan, 2016</xref>). We injected D-APV (5 μg/μl, 0.8–1 μl/injection, see Materials and Methods for detail) into the lateral ventricle of the contralateral S1 twice-daily from P4 to P12 and examined the callosal innervation pattern at P14 (<xref ref-type="fig" rid="fig7">Figure 7E–H</xref>). Compared with saline control, D-APV-treated pups developed unilateral muscle contractions in limbs on the opposite side of the injection (data not shown), suggesting the channel function of NMDAR had been blocked. However, the callosal innervation pattern in these pups was again similar to saline controls (<xref ref-type="fig" rid="fig7">Figure 7F–H</xref>). Taken together, these results indicate that NMDAR function in callosal targeting is independent of its channel activity.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>NMDAR regulates callosal circuit development independent of NMDAR channel activity.</title><p>(<bold>A–D</bold>) Blocking Ca<sup>2+</sup> influx through NMDAR by MK-801. MK-801 enters the open NMDAR channel and binds to the ‘blocking site’ located deep in the pore (<bold>A</bold>). Callosal innervation patterns in Saline (<bold>B</bold>) and MK-801 (<bold>C</bold>) injected mice at P14. (<bold>D</bold>) Quantification of fluorescence density. p=0.91. (<bold>E–H</bold>) Blocking NMDAR channel opening by D-APV. D-APV competitively inhibits glutamate binding site to NMDAR (<bold>E</bold>). Callosal innervation patterns in saline (<bold>F</bold>) and D-APV (<bold>G</bold>) injected mice at P14. (<bold>H</bold>) Quantification of fluorescence density. p=0.93. Scale bar: 500 μm for all images.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig7-v2.tif"/></fig></sec><sec id="s2-9"><title>EPHB2 protein expression is decreased in GluN1 KO mice</title><p>Our studies to this point led us to consider whether the NMDAR may mediate callosal axon targeting via interaction with other guidance signaling systems. Previous studies have shown that NMDAR subunits bind directly to EPHB axon guidance receptors (<xref ref-type="bibr" rid="bib7">Dalva et al., 2000</xref>). EPHB receptor tyrosine kinases and their transmembrane-ligands, the EPHRIN-B family, mediate short-distance cell–cell signaling and thus regulate many developmental processes at the interface between pattern formation and morphogenesis, including ordered neural maps (<xref ref-type="bibr" rid="bib30">Kania and Klein, 2016</xref>; <xref ref-type="bibr" rid="bib50">Niethamer and Bush, 2019</xref>). Further, several members of the EPH/EPHRIN family, including EPHRIN-B1 and EPHB2, are involved in earlier stages of CC midline axon crossing, strengthening their relevance in this context (<xref ref-type="bibr" rid="bib3">Bush and Soriano, 2009</xref>; <xref ref-type="bibr" rid="bib53">Orioli et al., 1996</xref>; <xref ref-type="bibr" rid="bib61">Robichaux et al., 2016</xref>). EPHB2 and NMDARs colocalize at postsynaptic dendrites, and the extracellular domain of NMDAR interacts directly with EPHB2, an interaction driven by activation of EPHB2 by clustered EPHRIN-B1 expressed in presynaptic axon terminals (<xref ref-type="bibr" rid="bib7">Dalva et al., 2000</xref>; <xref ref-type="bibr" rid="bib52">Nolt et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Palmer and Klein, 2003</xref>). Mice lacking EPHB2 have reduced levels of NMDARs at synapses in the hippocampus and cortex (<xref ref-type="bibr" rid="bib23">Henkemeyer et al., 2003</xref>; <xref ref-type="bibr" rid="bib65">Sheffler-Collins and Dalva, 2012</xref>), suggesting coordinated localization. EPHB2 also preferentially decreases Ca<sup>2+</sup>-dependent inactivation of GluN2B-containing NMDARs but not GluN2A-containing NMDARs at synapses of mature neurons (<xref ref-type="bibr" rid="bib52">Nolt et al., 2011</xref>). In addition, EPHB2 signaling leads to phosphorylation of GluN2B at tyrosine residue 1472 preventing clathrin-dependent endocytosis, and increasing the surface retention of GluN2B-containing NMDARs (<xref ref-type="bibr" rid="bib4">Chen and Roche, 2007</xref>; <xref ref-type="bibr" rid="bib52">Nolt et al., 2011</xref>; <xref ref-type="bibr" rid="bib68">Takasu et al., 2002</xref>). Taken together, these pieces of evidence suggested us that NMDAR may cooperate with EPHRIN-B/EPHB signaling during initial circuit formation.</p><p>We thus examined expression of EPHB2 in NMDAR KO mice by immunostaining. At P5, EPHB2 was found in both cortex and CC of controls (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A</xref>). However, in GluN1 KO mice, EPHB2 expression in the cortex was reduced (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1B</xref>). Western blots also confirmed that protein levels of EPHB2 were reduced at least 30% in GluN1 KO mice (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C–E</xref>) while mRNA levels of EPHB2 were unchanged (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1F</xref>). As discussed above, in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice, GluN1 was selectively deleted in excitatory neurons. Based on previous studies, the expression of GluN1 in interneurons (<xref ref-type="bibr" rid="bib35">Korotkova et al., 2010</xref>), oligodendrocytes, and oligodendrocyte precursor cells (<xref ref-type="bibr" rid="bib31">Káradóttir et al., 2005</xref>) in the cortex should not be affected in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice. To examine the expression of EPHB2 specifically in GluN1 KO cells, we crossed <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice with Cre-reporter mice – <italic>Rosa26<sup>fs-tdTomato</sup></italic> mice that exhibit tdTomato expression after Cre-mediated recombination. Supporting our hypothesis that loss of GluN1 leads to loss of EPHB2, the punctate staining of EPHB2 on cell membranes was completely lost in red (recombined) cells of <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> brain sections but not red cells of <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup>; Rosa26<sup>fs-tdTomato</sup></italic> brain sections (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). Taken together, we demonstrated that the loss of NMDAR caused the loss of EPHB2 selectively on cells that lack GluN1 after excision, thus explaining the 30% reduction in EPHB2 protein expression. Given the known physical association between NMDAR and EPHB2, these data suggest reciprocity in this stabilizing interaction and dendritic localization.</p></sec><sec id="s2-10"><title>NMDAR cooperates with EPHRIN-B/EPHB in controlling axon targeting in S1</title><p>EPHB2 and NMDARs colocalize at postsynaptic dendrites, and the extracellular domain of NMDAR interacts directly with EPHB2, an interaction driven by activation of EPHB2 by clustered EPHRIN-B1 expressed in presynaptic axon terminals (<xref ref-type="bibr" rid="bib7">Dalva et al., 2000</xref>). This is consistent with the possibility that EPHRIN-B1, expressed by the projecting neuronal axons, signals through EPHB2 and NMDAR, located on the target neurons, to regulate axon extension in the contralateral cortex (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). To test this prospect, we deleted EPHRIN-B1 in projecting neurons by electroporating vectors of Cre and EGFP at E15.5 in <italic>Efnb1<sup>fl/fl</sup></italic> mice and examined the initial callosal targeting at P6 (<xref ref-type="fig" rid="fig8">Figure 8B and C</xref>). In projecting neurons lacking EPHRIN-B1, callosal axons extended into the cortex past layer V, and many axons terminated in layer II/III (arrows in <xref ref-type="fig" rid="fig8">Figure 8C</xref>), similar to that observed in GluN1 KO mice at P6 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>NMDARs cooperate with EPHRIN-B/EPHB in controlling axon targeting in S1.</title><p>(<bold>A</bold>) EPHRIN-B1, expressed by the projecting neuronal axons, signals through EPHB2 and NMDAR, located on the target neurons, regulates axon extension in contralateral cortex. (<bold>B, C</bold>) Deleting EPHRIN-B1 in projecting neurons in <italic>Efnb1<sup>fl/fl</sup></italic> mice. Vectors expressing Cre and EGFP were delivered into S1 of all pups from <italic>Efnb1<sup>fl/wt</sup></italic> × <italic>Efnb1<sup>fl/wt</sup></italic> crosses by in utero electroporation at E15.5. Compared with control mice (<bold>B</bold>), ipsilaterally deleted mice showed earlier callosal innervation at P6 (<bold>C</bold>). (<bold>D, E</bold>) Blocking NMDAR function in target neurons by intraventricular injection of GluN1Ab in contralateral cortex, from P3 to P6. Compared with control RbIgG injected mice (<bold>D</bold>), GluN1Ab injected mice showed earlier callosal innervation at P6 (<bold>E</bold>). (<bold>F, G</bold>) Blocking EPHB function in target neurons by intraventricular injection of EPHRIN-B1-Fc in contralateral cortex, from P3 to P6. Compared with control Hum Fc injected mice, EPHRIN-B1-Fc injected mice showed earlier callosal innervation at P6 (<bold>G</bold>). (<bold>H, I</bold>) Blocking NMDAR and EPHB function simultaneously by GluN1Ab and EPHRIN-B1-Fc in contralateral cortex, from P3 to P6. Compared with control RbIgG + Hum IgG injected mice (<bold>H</bold>), GluN1Ab + EPHRIN-B1-Fc injected mice showed earlier callosal innervation at P6 (<bold>I</bold>). (<bold>J</bold>) Quantification of fluorescence density. Scale bar: 500 μm for all images. Arrows pointed out axon terminals in the target cortex.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>The protein but not RNA level of EPHB2 was reduced in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice at P8.</title><p>(<bold>A, B</bold>) EPHB2 protein expression is decreased in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice at P5. In control <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup></italic> mice, EPHB2 was expressed both in CC and cortex (<bold>A</bold>). EPHB2 in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice was decreased in cortex (<bold>B</bold>). (<bold>C</bold>) Western blot analysis of cortical protein extracts from P8 S1 showed that, relative to the loading control beta-tubulin (β-Tub) and GAPDH, lower levels of EPHB2 were observed in the five samples of <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice compared to the five samples of controls. (<bold>D</bold>) Quantification of protein levels relative to β-Tub. p=0.001. (<bold>E</bold>) Quantification of protein levels relative to GAPDH. p&lt;0.0001. (<bold>F</bold>) The quantitative polymerase chain reaction (qPCR) analysis showed no expression difference of EPHB2 between <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice and controls. Scale bar: 500 μm for <bold>A</bold>, <bold>B</bold>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig8-figsupp1-v2.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>The cell membrane expression of EPHB2 was absent in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic>; <italic>Rosa26<sup>fs-tdTomato</sup></italic> positive cells.</title><p>(<bold>A</bold>) We crossed <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup></italic> mice with Cre-reporter <italic>Rosa26<sup>fs-tdTomato</sup></italic> mice to produce GluN1 knockout cells labeled with red fluorescence. (<bold>B</bold>) 12 µm coronal brain sections from P8 <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup>; Rosa26<sup>fs-tdTomato</sup></italic> and <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice of the same litter. Immunostaining of EPHB2 was done in all brain sections. Broad arrowheads pointed the cells with Cre recombination. Triangle arrowheads pointed to cells with Cre recombination. V shaped arrowheads pointed to cells without Cre recombination. In control <italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice, EPHB2 signals were detected on both Cre recombination and non-Cre recombination cells. However, in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice, EPHB2 signals were only detected on non-Cre recombination cells, but absent on Cre recombination cells with deletion of GluN1. (<bold>C</bold>) Quantification of fluorescence density of EPHB2 immunostaining for each cell. Compared to control (<italic>Emx1<sup>cre/+</sup>; Grin1<sup>wt/wt</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice), the protein expression of EPHB2 in Cre recombination cells in <italic>Emx1<sup>cre/+</sup>; Grin1<sup>fl/fl</sup>; Rosa26<sup>fs-tdTomato</sup></italic> mice was dramatically decreased. p&lt;0.0001. Scale bar: 10 μm for all images in B. <italic>R26<sup>tdT</sup>: Rosa26<sup>fs-tdTomato</sup>.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-59612-fig8-figsupp2-v2.tif"/></fig></fig-group><p>Since this manipulation does not take into account potential compensation by other EPHRIN-B ligands, we blocked all EPHB2 signaling in the contralateral cortex by intraventricular injection of soluble EPHRIN-B1-Fc, from P3 to P6 and examined the initial callosal targeting at P6 (<xref ref-type="fig" rid="fig8">Figure 8F and G</xref>). EPHRINs have to be clustered in a cell membrane or artificially with, for example, antibodies to efficiently activate EPH receptors (<xref ref-type="bibr" rid="bib8">Davis et al., 1994</xref>). Unclustered soluble EPHRINs bind EPH receptors but act as antagonists (<xref ref-type="bibr" rid="bib71">Vearing and Lackmann, 2005</xref>). Compared with littermate controls, contralateral injection of soluble EPHRIN-B1-Fc led to increased callosal innervation at P6 with axons penetrating to superficial layers (<xref ref-type="fig" rid="fig8">Figure 8F, G, and J</xref>). These results support the idea that EPHRIN-B1-EPHB2 play important roles in controlling callosal axon penetration into the contralateral S1 cortex.</p><p>To further determine whether there is collaboration between NMDAR and EPH-B signaling, we developed a way to assess blockade of both systems and determine if this blockade was additive, synergistic or likely acting in the same pathway. We blocked NMDAR in contralateral/target cortex by intraventricular injection of anti-GluN1 antibodies, from P3 to P6, and examined the initial callosal targeting at P6 (<xref ref-type="fig" rid="fig8">Figure 8D and E</xref>). Compared with controls, contralateral injection of anti-GluN1 antibodies caused increased callosal innervation at P6 and penetration to superficial layers of cortex (<xref ref-type="fig" rid="fig8">Figure 8D, E, and J</xref>). Critically, blocking NMDAR and EPHRIN-B1-EPHB2 signaling simultaneously in contralateral cortex by injecting both anti-GluN1 antibody and EPHRIN-B1-Fc did not show any additive or synergistic effects (<xref ref-type="fig" rid="fig8">Figure 8H–J</xref>). This suggests that in fact NMDAR and EPHRIN-B1-EPHB2 are in the same pathway in regulating callosal targeting in S1 and is consistent with our other findings.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we found that NMDARs cooperate with EPHRIN-B/EPHB in controlling callosal circuit formation and demonstrated that it is GluN2B-containing NMDARs in target S1 cortex that regulate callosal axon targeting in S1. In mutants where either GluN2B or GluN1 are disrupted, there is excess axonal growth throughout S1. Either genetic or antibody-mediated loss of NMDAR specifically in the target hemisphere disrupted this projection. We found that this begins at P6 when axons that should terminate in deep cortical layers of target S1 instead project more superficially. Once this targeting defect begins, it continues to worsen. We believe this phenotype is most consistent with a loss of a repellant activity that normally restricts commissural axonal projections to the S1 cortex at initial stages of this process (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Once these axons aberrantly penetrate through the deeper cortical layers of S1 in the GluN1 mutants, this phenotype continues to worsen. A systematic role for NMDAR in this process was a surprise and has significant implications for disorders where NMDAR function is lost due to mutations or due to antibody-mediated disruption of NMDAR surface distribution. We predict this would be a potent disruptor of circuit formation during development certainly in this callosal circuit, but likely others as well.</p><sec id="s3-1"><title>Mechanisms for the formation of homotopic callosal projection during development</title><p>In previous studies (<xref ref-type="bibr" rid="bib81">Zhou et al., 2013</xref>), we showed that the medial-lateral topography of callosal neurons is tightly constrained by the D-V position of their axons within the CC. The axon position within the CC determines the contralateral cortical projection, with more dorsally located axons projecting medially and ventrally located axons projecting laterally. The complementary expression of chemotropic guidance cue Semaphorin3A (Sem3A) and its receptor Neuropilin-1 (Nrp1) contributes to this axonal order within the CC. The studies of genetic manipulations showed that Sema3A/Nrp1 signaling contributes to the topographic order of axons within the CC but is not involved in the axon position-dependent projection to the contralateral target cortex. Here, in this study, we demonstrated that contralateral/target expression of NMDAR controls the pattern of callosal projections to contralateral target S1. Interestingly, despite the disruption of targeting within S1 in mice with disrupted NMDAR, there is little evidence of ectopic projection to other cortical areas. This indicates that there are still other cues that regulate the generic projection to S1 but that the mechanisms we have uncovered help govern the distribution of these axons within S1.</p></sec><sec id="s3-2"><title>NMDARs cooperate with EPHRIN-B/EPHB to regulate axon extension into the cortex</title><p>Given the longstanding understanding of important roles for neural activity in the wiring of circuits and the generation of cortical maps, we expected that the function of NMDAR in this process would be due to the critical role of NMDAR in excitatory activity in the developing brain as synapses form. However, our data show that NMDAR ion channel function is not necessary for its role in somatosensory callosal targeting. These data are consistent with the idea that NMDAR protein complexes containing GluN1 and GluN2B are critical for commissural projection. Our findings suggest that without NMDAR containing GluN1 and GluN2B in the target cortex, there is earlier and increased callosal innervation of S1 starting at P6, when callosal axons start entering the contralateral cortex. We believe that this observation indicates that either loss of NMDAR leads to an increase in the attractiveness of S1 cortex or that loss of NMDAR leads to loss of a repellant activity in the cortex that normally limits axon growth into superficial layers of S1, until axons reach the S1/S2 border. This realization led us to consider whether there might be a role for NMDAR complexes in collaborating with already known axon guidance mechanisms.</p><p>EPHRIN-B/EPHB signals are well-known repulsive axon guidance cues. Because EPHB2 is necessary for localization of NMDAR to postsynaptic terminals, we wondered if this requirement was reciprocal and found indeed that it is – when NMDARs are lost, membrane based EPHB2 protein expression in target neurons is lost as well (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). This result suggests that NMDAR reciprocally regulates the localization of EPHB2. In addition, the NMDAR interaction with EPHB2 is driven by the stimulation of EPHB2 by clustered EPHRIN-B1 expressed in presynaptic axon terminals, indicating that the interaction may regulate axon guidance and termination. When we deleted EPHRIN-B1 only in projecting callosal axons, this also led to excess ingrowth into the S1 cortex visible from P6 to P8. That this phenotype is less severe than the NMDAR phenotype is most likely due to redundancy with other EPHRIN-B ligands also expressed in projecting axons. To globally disrupt EPHB-EPHRIN-B interactions we injected EPHRIN-B1-Fc fragments and found that these also disrupted the somatosensory callosal targeting as efficiently as anti-NMDAR antibodies; furthermore, these two treatments were neither additive nor synergistic, implying they act through a common pathway. Further studies will examine whether this phenotype is due to loss of repulsive activity of EPHRIN-B/EPHB signals, and whether it is through forward EPHB or reverse EPHRIN-B signaling or both.</p></sec><sec id="s3-3"><title>The refinement of callosal innervation pattern</title><p>The production of transient, exuberant axons, and axonal branches is a general phenomenon in development across species and systems (<xref ref-type="bibr" rid="bib9">De León Reyes et al., 2019</xref>; <xref ref-type="bibr" rid="bib14">Fenlon et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Hand et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Innocenti, 2020</xref>; <xref ref-type="bibr" rid="bib28">Innocenti and Price, 2005</xref>; <xref ref-type="bibr" rid="bib41">Luo and O'Leary, 2005</xref>; <xref ref-type="bibr" rid="bib60">Ribeiro Gomes et al., 2020</xref>). Our data indicate that NMDAR are required to collaborate with EPHRIN-B/EPHB in target cortex, and the most parsimonious conclusion is that this acts as a repellant to limit early growth of callosal axons into S1 cortex. These phenotypes are seen first at P6 when axons inappropriately enter superficial cortex in S1 so that by P30 (when the animals die) there is a nearly sixfold increase in axonal extension into S1. This is consistent with a role for NMDAR in controlling initial projection into S1 but probably also later regulating refinement of these inappropriate projections by pruning – both core functions of axonal repellants. Previous studies have observed the role of NMDAR in axon elimination (<xref ref-type="bibr" rid="bib6">Colonnese and Constantine-Paton, 2006</xref>; <xref ref-type="bibr" rid="bib24">Henson et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Personius et al., 2016</xref>; <xref ref-type="bibr" rid="bib58">Rabacchi et al., 1992</xref>; <xref ref-type="bibr" rid="bib59">Rajan et al., 1999</xref>; <xref ref-type="bibr" rid="bib80">Zhang et al., 2013</xref>). In vivo time-lapse images of retinal axons from albino <italic>Xenopus</italic> tadpoles show that correlated neural activity influences axon branch dynamics of retinal axons in the optic tectum (<xref ref-type="bibr" rid="bib63">Ruthazer et al., 2003</xref>). The axon branches whose activity is not correlated with that of their neighbors are selectively eliminated. However, the selective elimination can be abolished by blocking the Ca<sup>2+</sup> influx of NMDAR by its antagonist MK-801. When we blocked the Ca<sup>2+</sup> influx of NMDAR by MK-801 or D-APV, even though the overall callosal innervation pattern of somatosensory cortex was not affected, there were some subtle, local laminar-specific innervation differences at the S1/S2 border, suggesting that the refinement of axon arborization may rely on the Ca<sup>2+</sup> influx-mediated activity changes through NMDAR.</p><p>Regarding previous roles of EPHRIN-B/EPHB signaling in pruning, this pathway was previously shown to be involved in infrapyramidal bundle pruning in dentate gyrus (<xref ref-type="bibr" rid="bib77">Xu and Henkemeyer, 2009</xref>) and it is known that activation of EPHB by EPHRIN-B potentiates Ca<sup>2+</sup> influx of NMDA receptor (<xref ref-type="bibr" rid="bib68">Takasu et al., 2002</xref>). These lines of evidence suggest that NMDAR and EPHRIN-B/EPHB signaling may cooperate in the refinement of the callosal innervation pattern and perhaps in other circuits. Further studies will examine how and whether NMDAR regulates EPHRIN-B/EPHB signaling directly and the detailed molecular mechanism underlying their collaboration to regulate callosal innervation patterns in the primary somatosensory cortex.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Experimental model and subject details</title><p>All animal protocols were in accordance with the regulations of the National Institute of Health and approved by the University of California San Francisco Institutional Animal Care and Use Committee (IACUC). Floxed GluN1<italic>Grin1</italic> allele (Stock #005246), EMX1-Cre (Stock #005628) and <italic>Rosa26&lt;fs-tdTomato&gt;</italic> Cre reporter allele (Stock # <ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/007914">007914</ext-link>) were obtained from Jackson Laboratories (Bar Harbor, ME, USA). Floxed <italic>Grin2a</italic> and <italic>Grin2b</italic> alleles were provided by the laboratory of Prof. Roger Nicoll. Floxed <italic>EphrinB1</italic> allele was provided by the laboratory of Prof. Jeffrey Bush. Wild-type CD1 mice were obtained from <ext-link ext-link-type="uri" xlink:href="http://www.criver.com/">Charles River Laboratories.</ext-link> Male and female embryos at embryonic (E) 12.5 and E15.5 were used for the in utero electroporation, and pups between postnatal day 0 (P0) to 30 (P30) for the experiments.</p></sec><sec id="s4-2"><title>In utero electroporation</title><p>DNA solution including the plasmid and 0.04% fast green was injected into the medial region of the lateral ventricle of the embryonic brain with a glass micropipette. Electrical pulses then were delivered to embryos by electrodes connected to a square-pulse generator (ECM830, BTX). For each electroporation, five 35 V pulses of 50 ms were applied at 1 s intervals. After the electroporation, the uterus was returned to the abdominal cavity, followed by suturing of the abdominal wall and skin. Mice were perfused at different postnatal stages using 4% paraformaldehyde followed by post-fixed overnight and incubation in 30% sucrose at 4°C. 35 μm-thick coronal sections were obtained using cryostat sectioning.</p></sec><sec id="s4-3"><title>Plasmid</title><p>Plasmid of pCAGGS-Cre and pCAGGS-CreERT was obtained from Addgene. The ubiquitin-EGFP plasmid used was from a previous study (<xref ref-type="bibr" rid="bib81">Zhou et al., 2013</xref>).</p></sec><sec id="s4-4"><title>Antibodies: Antibodies for intraventricular injection</title><p>Commercial anti-NMDAR antibody is against amino acid residues 385–399 in the N-terminus of GluN1 and was made in Rabbit (AGC-001, Alomone labs). Rabbit IgG (<bold>#</bold>31235, Invitrogen) served as control. Recombinant Mouse EPHRIN-B1 Fc Chimera Protein was obtained from R and D (473-EB). Recombinant Human IgG1 Fc Protein (110-HG, R and D) served as control. Antibodies for immunostaining: Rabbit anti-GluN1 (1:500, AGC-001, Alomone labs), anti-vGlut2 (1:200, AB2251, Millipore), goat anti-EphB2 (1:50, AF467, R and D), anti-cleaved caspase-3 (<bold>#</bold>9661S, Cell Signaling), anti-Rabbit 594 (#711-585-152, Jackson ImmunoResearch), and anti-guinea pig 488 (A-11073, Invitrogen). Antibodies for western blot: rabbit anti-GluN1 (AB9864, Millipore), rabbit anti-GluN2A (#4205, Cell signaling), rabbit anti-GluN2B (#4212, Cell signaling), goat anti-EPHB2 (1:1000, AF467, R and D), rabbit anti-GAPDH (1:5000, #2118, Cell Signaling), rabbit anti-β tubulin (1:5000, <bold>#</bold>2128, Cell Signaling), IRDye 680RD Donkey anti-Goat IgG(H+L) Ab (1:10,000, <bold>#</bold>926–68074, Li-Cor), and IRDye 800CW Goat × Rabbit IgG(H+L) Ab (1:20,000, <bold>#</bold>925–32211, Li-Cor).</p></sec><sec id="s4-5"><title>Intraventricular injection</title><p>Antibodies/Fc-fragment was injected to lateral ventricular of pups by glass pipette with a sharp bevel at 45° (BV-10 Micropipette Beveler, Sutter instrument). The diameter of pipette tip was ~40–80 μm (<xref ref-type="bibr" rid="bib73">Vogt et al., 2015</xref>). The concentrations for antibody injections were 3.2 μg/μl for the commercial anti-GluN1 antibody and Rabbit IgG. The concentrations for Fc injections were 2 μg/μl for EPHRIN-B1 Fc and Human IgG1 Fc. Antibodies/Fc-fragment was injected twice-daily and the injection volume was 0.8–1 μl for each injection.</p></sec><sec id="s4-6"><title>MK-801 systemic injection</title><p>EGFP positive pups were given intraperitoneal (i.p.) injection of MK-801 (1 mg/kg, M107-25MG, Sigma) or equivalent volume of 0.9% saline once-daily. See the following for the criteria of selecting effective dose of MK-801. Based on literature, the single dose of MK-801 for acute i.p. administration is up to 1–10 mg/kg (<xref ref-type="bibr" rid="bib17">Foster et al., 1988</xref>); the daily dose of MK-801 for chronic i.p. administration is around 0.3–0.6 mg/kg (<xref ref-type="bibr" rid="bib51">Nilsson et al., 1997</xref>; <xref ref-type="bibr" rid="bib70">Uttl et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Zuo et al., 2006</xref>). To optimize the dose for chronic administration, MK-801 was given to three groups of pups (each group had four pups with mixed genders) from P4 to P9 with the doses of 1 mg/kg, 10 mg/kg, and 20 mg/kg, respectively. Saline was given to four pups of the same litter as control. We measured body weights of all pups every day before i.p. administration. The pups in saline group always had abundant milk in their stomachs and gained weight rapidly. The pups with the dose of 1 mg/kg had milk in their stomachs and gained weight, but very slowly. Some even lost weights. All MK-801-treated pups developed abnormal behavior-opisthotonic posturing for heads and four limbs, similar to the abnormal postures in children with anti-NMDAR encephalitis (<xref ref-type="bibr" rid="bib15">Florance et al., 2009</xref>). The doses of 10 mg/kg and 20 mg/kg were too close to lethal dose and the pups lost weight and died within 2–3 days. Thus, we chose 1 mg/kg for our experiment. The weight loss and abnormal behavior had been reported in neonatal mice after MK-801 administration (<xref ref-type="bibr" rid="bib13">Facchinetti et al., 1993</xref>; <xref ref-type="bibr" rid="bib20">Griesbach and Amsel, 1998</xref>; <xref ref-type="bibr" rid="bib76">Wu et al., 2005</xref>).</p></sec><sec id="s4-7"><title>D(-)−2-amino-5-phosphonopentanoic acid (D-APV) intraventricular injection</title><p>Because D-APV poorly penetrates the blood–brain barrier (BBB) when administered systemically, we injected it directly into the lateral ventricle of targeted cortex. EGFP positive pups were given D-APV (5 μg/μl, Millipore-sigma, 165304–5 MG) twice-daily at an injection volume of 0.8–1 μl/injection. See section Intraventricular injection for injection details. See the following for the criteria of selecting effective dose of D-APV. Based on literature, one-time infusion of 5 μg D-APV into the basolateral amygdala of adult rat (~250 g) caused memory deficit persistent for at least 4 weeks (<xref ref-type="bibr" rid="bib43">Milton et al., 2008</xref>). Blocking NMDARs by intracerebral infusion of 0.5 μl of 500 μM D-APV into P7 mouse pup reduced somatic calcium transients in pyramidal cells evoked by lateral olfactory tract stimulation, and caused memory deficits both in short-term (3 hr) and long-term (24 hr) odor preference memory (<xref ref-type="bibr" rid="bib48">Mukherjee and Yuan, 2016</xref>). 0.5 μl of 500 μM D-APV is equal to 0.05 μg D-APV (molecular weight of D-APV: 197.13). To optimize the dose for chronic administration, intraventricular D-APV injection was given to two groups of pups (each group had four pups with mixed genders) from P4 (~4 g) to P9 (~8 g) with the concentrations of 5 μg/μl and 10 μg/μl twice-daily (0.8–1 μl/injection), respectively. Saline was given to four pups of the same litter as control. The body weight of all pups was measured before intraventricular injection. There were no body weight differences between saline-treated and D-APV-treated mice. However, D-APV-treated pups in both 5 μg/μl-treated and 10 μg/μl-treated groups developed unilateral muscle contractions in limbs on the opposite side of the injection within 10 min after injection, similar to the abnormal movements seen in MK-801-treated mice but only restricting in one side of body. No pups died during the 6 days of injections. As 5 μg/μl-treated and 10 μg/μl-treated had no dose-dependent effect on the abnormal behavior and based on dosage of D-APV used in literature, we chose 5 μg/μl D-APV treatment for our experiment.</p></sec><sec id="s4-8"><title>Slice preparation and imaging</title><p>Mice were perfused with saline followed by 4% paraformaldehyde in phosphate buffered saline (PBS), pH 7.4. Brains were removed from mice and post-fixed in 4% paraformaldehyde overnight before being placed in 30% sucrose solution. The brains were then cut into 35 µm sections with cryostat (Leica VT1200S). Sections were imaged by Zeiss Axioscan Z.1 (Zeiss, Thornwood, NY, USA) with a 20× objective.</p></sec><sec id="s4-9"><title>Immunostaining</title><p>Mouse pups were perfused with saline followed by 4% paraformaldehyde in PBS, pH 7.4. Brains were removed from mice and post-fixed in 4% paraformaldehyde overnight before being placed in 30% sucrose solution. The brains were then cut into 12 µm sections with cryostat (Leica VT1200S). Non-specific binding was blocked by adding 5% normal goat/donkey serum during pre-incubation and incubations in 1× PBS containing 0.05% TritonX-100. The primary antibodies were applied overnight at 4°. Secondary antibodies were applied for 1–2 hr at 4° and nuclei were stained with DAPI. Slides were mounted with Prolong Gold Anti-fade Mountant (P36930, Invitrogen).</p></sec><sec id="s4-10"><title>Western blotting</title><p>Mouse brain tissue of somatosensory cortex from <italic>Emx1<sup>cre/+</sup>; Grin1</italic><sup>fl/fl</sup> mice or littermate controls at P8 were collected for western blotting. Five mouse samples for each group. The protocol we used as described before (<xref ref-type="bibr" rid="bib78">Yabut et al., 2015</xref>).</p></sec><sec id="s4-11"><title>Primers for RT-PCR</title><p>Primers for EphB2: Forward Primer-<named-content content-type="sequence">ATTATTTGCCCCAAAGTGGACTC</named-content>; Reverse Primer-<named-content content-type="sequence">GCAGCGGGGTATTCTCCTTC</named-content>.</p></sec><sec id="s4-12"><title>RT-PCR</title><p>Mouse brain tissue of somatosensory cortex from <italic>Emx1<sup>cre/+</sup>; Grin1</italic><sup>fl/fl</sup> mice or littermate controls at P8 were collected for RT-PCR. Six mouse samples for each group. The protocol we used as described before (<xref ref-type="bibr" rid="bib78">Yabut et al., 2015</xref>).</p></sec><sec id="s4-13"><title>Quantification and statistical analysis</title><sec id="s4-13-1"><title>Callosal axon distribution analysis</title><p>Using the segmented line tool in ImageJ, a line was drawn with a width of 200 pixels from medial S1 to lateral S1/S2 border along cortical layer II/III. Fluorescence distribution was measured along the line by using ‘Plot Profile’ under ‘Analyze’ in ImageJ and produced data sets with distance points along the line (X) and fluorescence intensity (Y). The data was exported to Excel. In Excel, fluorescence intensity values (Y) were normalized by dividing by the max Y fluorescence value for that group. Finally, results were analyzed by using XY statistics in Prism version 5.0 (GraphPad Software).</p></sec><sec id="s4-13-2"><title>Callosal axon density analysis</title><p>Sections were imaged using a Zeiss Axioscan Z.1 (Zeiss, Thornwood, NY, USA) with 20× objective over whole brain section. Each image was made up by the compression of three slices in 4 μm Z-stack. For each brain, only one section was chosen for data quantification. The callosal axon density (fluorescence density) in S1 was quantitatively analyzed by ImageJ software. First, each picture was converted to an 8-bit image, and then Brightness/Contrast (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>) and Threshold Ranges (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>) were set. Threshold Range was set to eliminate background fluorescence from affecting fluorescent density. Second, the cortical S1 region in the target side was identified according to Dapi staining as previously described (<xref ref-type="bibr" rid="bib81">Zhou et al., 2013</xref>) and a box was drawn to encompass only the S1 (box I in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>). Third, fluorescence density was quantified in the S1 by counting the number of pixels within the threshold range and dividing by total number of pixels in the area. This is done by selecting ‘Area Fraction’ and ‘Limit to Threshold’ in ImageJ → Analyze → Set Measurement. Finally, the axon density in S1 was normalized by the average fluorescence density of midline for each image (box II in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>). The average fluorescence density of midline was calculated by measuring the fluorescence density of six non-overlapping points around the midline and averaging the values. A fixed sized box was used for all measurements of midline fluorescence density. Since a fixed sized box was used (total number of pixels is fixed for all), ‘Area’ instead of ‘Area Fraction’ was used for analysis. Results were analyzed by using two-tailed t-test in Prism version 5.0 (GraphPad Software). Please note that control groups and experimental groups followed exactly the same settings of measurements.</p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Prof. Roger Nicoll and Jillian Iafrati for providing <italic>Grin2a<sup>fl/fl</sup></italic> and <italic>Grin2b<sup>fl/fl</sup></italic> mice. We thank Wucheng Tao in Prof. Roger Nicoll’s lab for suggestions on the experimental design of MK-801 in vivo injection. We thank Drs. Ariele L Greenfield, Christopher M Bartley, and Michael R Wilson for critical comments and editing of this manuscript. Work in the Pleasure lab was supported by R56 MH119435, R01MH122471, UCSF Weill Institute for Neurosciences Innovation Award, and UCSF Marcus Program in Precision Medicine Innovation Transformative Integrated Research Initiative. JOB was supported by R01DE023337 from NIH/NIDCR.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (AN176415) of the University of California San Francisco.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-59612-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyses during this study are included in the manuscript.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adelsberger</surname> <given-names>H</given-names></name><name><surname>Garaschuk</surname> <given-names>O</given-names></name><name><surname>Konnerth</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cortical calcium waves in resting newborn mice</article-title><source>Nature Neuroscience</source><volume>8</volume><fpage>988</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1038/nn1502</pub-id><pub-id pub-id-type="pmid">16007081</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allène</surname> <given-names>C</given-names></name><name><surname>Cattani</surname> <given-names>A</given-names></name><name><surname>Ackman</surname> <given-names>JB</given-names></name><name><surname>Bonifazi</surname> <given-names>P</given-names></name><name><surname>Aniksztejn</surname> <given-names>L</given-names></name><name><surname>Ben-Ari</surname> <given-names>Y</given-names></name><name><surname>Cossart</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Sequential generation of two distinct synapse-driven network patterns in developing neocortex</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>12851</fpage><lpage>12863</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3733-08.2008</pub-id><pub-id pub-id-type="pmid">19036979</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname> <given-names>JO</given-names></name><name><surname>Soriano</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>1586</fpage><lpage>1599</lpage><pub-id pub-id-type="doi">10.1101/gad.1807209</pub-id><pub-id pub-id-type="pmid">19515977</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>BS</given-names></name><name><surname>Roche</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of NMDA receptors by phosphorylation</article-title><source>Neuropharmacology</source><volume>53</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2007.05.018</pub-id><pub-id pub-id-type="pmid">17644144</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collingridge</surname> <given-names>GL</given-names></name><name><surname>Isaac</surname> <given-names>JT</given-names></name><name><surname>Wang</surname> <given-names>YT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Receptor trafficking and synaptic plasticity</article-title><source>Nature Reviews Neuroscience</source><volume>5</volume><fpage>952</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1038/nrn1556</pub-id><pub-id pub-id-type="pmid">15550950</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colonnese</surname> <given-names>MT</given-names></name><name><surname>Constantine-Paton</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Developmental period for N-methyl-D-aspartate (NMDA) receptor-dependent synapse elimination correlated with visuotopic map refinement</article-title><source>The Journal of Comparative Neurology</source><volume>494</volume><fpage>738</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1002/cne.20841</pub-id><pub-id pub-id-type="pmid">16374812</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalva</surname> <given-names>MB</given-names></name><name><surname>Takasu</surname> <given-names>MA</given-names></name><name><surname>Lin</surname> <given-names>MZ</given-names></name><name><surname>Shamah</surname> <given-names>SM</given-names></name><name><surname>Hu</surname> <given-names>L</given-names></name><name><surname>Gale</surname> <given-names>NW</given-names></name><name><surname>Greenberg</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>EphB receptors interact with NMDA receptors and regulate excitatory synapse formation</article-title><source>Cell</source><volume>103</volume><fpage>945</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)00197-5</pub-id><pub-id pub-id-type="pmid">11136979</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>Gale</surname> <given-names>NW</given-names></name><name><surname>Aldrich</surname> <given-names>TH</given-names></name><name><surname>Maisonpierre</surname> <given-names>PC</given-names></name><name><surname>Lhotak</surname> <given-names>V</given-names></name><name><surname>Pawson</surname> <given-names>T</given-names></name><name><surname>Goldfarb</surname> <given-names>M</given-names></name><name><surname>Yancopoulos</surname> <given-names>GD</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity</article-title><source>Science</source><volume>266</volume><fpage>816</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1126/science.7973638</pub-id><pub-id pub-id-type="pmid">7973638</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De León Reyes</surname> <given-names>NS</given-names></name><name><surname>Mederos</surname> <given-names>S</given-names></name><name><surname>Varela</surname> <given-names>I</given-names></name><name><surname>Weiss</surname> <given-names>LA</given-names></name><name><surname>Perea</surname> <given-names>G</given-names></name><name><surname>Galazo</surname> <given-names>MJ</given-names></name><name><surname>Nieto</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transient callosal projections of L4 neurons are eliminated for the acquisition of local connectivity</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4549</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12495-w</pub-id><pub-id pub-id-type="pmid">31591398</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dingledine</surname> <given-names>R</given-names></name><name><surname>Borges</surname> <given-names>K</given-names></name><name><surname>Bowie</surname> <given-names>D</given-names></name><name><surname>Traynelis</surname> <given-names>SF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The glutamate receptor ion channels</article-title><source>Pharmacological Reviews</source><volume>51</volume><fpage>7</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">10049997</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dore</surname> <given-names>K</given-names></name><name><surname>Aow</surname> <given-names>J</given-names></name><name><surname>Malinow</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The emergence of NMDA receptor metabotropic function: insights from imaging</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>8</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2016.00020</pub-id><pub-id pub-id-type="pmid">27516738</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname> <given-names>JP</given-names></name><name><surname>Ladépêche</surname> <given-names>L</given-names></name><name><surname>Seth</surname> <given-names>H</given-names></name><name><surname>Bard</surname> <given-names>L</given-names></name><name><surname>Varela</surname> <given-names>J</given-names></name><name><surname>Mikasova</surname> <given-names>L</given-names></name><name><surname>Bouchet</surname> <given-names>D</given-names></name><name><surname>Rogemond</surname> <given-names>V</given-names></name><name><surname>Honnorat</surname> <given-names>J</given-names></name><name><surname>Hanse</surname> <given-names>E</given-names></name><name><surname>Groc</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>842</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1002/embj.201386356</pub-id><pub-id pub-id-type="pmid">24591565</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facchinetti</surname> <given-names>F</given-names></name><name><surname>Ciani</surname> <given-names>E</given-names></name><name><surname>Dall'Olio</surname> <given-names>R</given-names></name><name><surname>Virgili</surname> <given-names>M</given-names></name><name><surname>Contestabile</surname> <given-names>A</given-names></name><name><surname>Fonnum</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801</article-title><source>Developmental Brain Research</source><volume>74</volume><fpage>219</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/0165-3806(93)90007-W</pub-id><pub-id pub-id-type="pmid">8104744</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenlon</surname> <given-names>LR</given-names></name><name><surname>Suárez</surname> <given-names>R</given-names></name><name><surname>Richards</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The anatomy, organisation and development of contralateral callosal projections of the mouse somatosensory cortex</article-title><source>Brain and Neuroscience Advances</source><volume>1</volume><elocation-id>239821281769488</elocation-id><pub-id pub-id-type="doi">10.1177/2398212817694888</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florance</surname> <given-names>NR</given-names></name><name><surname>Davis</surname> <given-names>RL</given-names></name><name><surname>Lam</surname> <given-names>C</given-names></name><name><surname>Szperka</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Ahmad</surname> <given-names>S</given-names></name><name><surname>Campen</surname> <given-names>CJ</given-names></name><name><surname>Moss</surname> <given-names>H</given-names></name><name><surname>Peter</surname> <given-names>N</given-names></name><name><surname>Gleichman</surname> <given-names>AJ</given-names></name><name><surname>Glaser</surname> <given-names>CA</given-names></name><name><surname>Lynch</surname> <given-names>DR</given-names></name><name><surname>Rosenfeld</surname> <given-names>MR</given-names></name><name><surname>Dalmau</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents</article-title><source>Annals of Neurology</source><volume>66</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1002/ana.21756</pub-id><pub-id pub-id-type="pmid">19670433</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname> <given-names>D</given-names></name><name><surname>Yuzaki</surname> <given-names>M</given-names></name><name><surname>Soares</surname> <given-names>HD</given-names></name><name><surname>Ng</surname> <given-names>L</given-names></name><name><surname>Luk</surname> <given-names>DC</given-names></name><name><surname>Sheng</surname> <given-names>M</given-names></name><name><surname>Stewart</surname> <given-names>CL</given-names></name><name><surname>Morgan</surname> <given-names>JI</given-names></name><name><surname>Connor</surname> <given-names>JA</given-names></name><name><surname>Curran</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death</article-title><source>Neuron</source><volume>13</volume><fpage>325</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(94)90350-6</pub-id><pub-id pub-id-type="pmid">8060614</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname> <given-names>AC</given-names></name><name><surname>Gill</surname> <given-names>R</given-names></name><name><surname>Woodruff</surname> <given-names>GN</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation</article-title><source>The Journal of Neuroscience</source><volume>8</volume><fpage>4745</fpage><lpage>4754</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.08-12-04745.1988</pub-id><pub-id pub-id-type="pmid">2904493</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golshani</surname> <given-names>P</given-names></name><name><surname>Gonçalves</surname> <given-names>JT</given-names></name><name><surname>Khoshkhoo</surname> <given-names>S</given-names></name><name><surname>Mostany</surname> <given-names>R</given-names></name><name><surname>Smirnakis</surname> <given-names>S</given-names></name><name><surname>Portera-Cailliau</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Internally mediated developmental desynchronization of neocortical network activity</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>10890</fpage><lpage>10899</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2012-09.2009</pub-id><pub-id pub-id-type="pmid">19726647</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname> <given-names>JA</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Usui</surname> <given-names>H</given-names></name><name><surname>During</surname> <given-names>MJ</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Nicoll</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo</article-title><source>Neuron</source><volume>71</volume><fpage>1085</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.08.007</pub-id><pub-id pub-id-type="pmid">21943605</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griesbach</surname> <given-names>GS</given-names></name><name><surname>Amsel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Immediate and long-term effects of neonatal MK-801 treatment on nonspatial learning</article-title><source>PNAS</source><volume>95</volume><fpage>11435</fpage><lpage>11439</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.19.11435</pub-id><pub-id pub-id-type="pmid">9736754</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahm</surname> <given-names>JO</given-names></name><name><surname>Cramer</surname> <given-names>KS</given-names></name><name><surname>Sur</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Pattern formation by retinal afferents in the ferret lateral geniculate nucleus: developmental segregation and the role of N-methyl-D-aspartate receptors</article-title><source>The Journal of Comparative Neurology</source><volume>411</volume><fpage>327</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19990823)411:2&lt;327::AID-CNE12&gt;3.0.CO;2-#</pub-id><pub-id pub-id-type="pmid">10404257</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hand</surname> <given-names>RA</given-names></name><name><surname>Khalid</surname> <given-names>S</given-names></name><name><surname>Tam</surname> <given-names>E</given-names></name><name><surname>Kolodkin</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Axon dynamics during neocortical laminar innervation</article-title><source>Cell Reports</source><volume>12</volume><fpage>172</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.026</pub-id><pub-id pub-id-type="pmid">26146079</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henkemeyer</surname> <given-names>M</given-names></name><name><surname>Itkis</surname> <given-names>OS</given-names></name><name><surname>Ngo</surname> <given-names>M</given-names></name><name><surname>Hickmott</surname> <given-names>PW</given-names></name><name><surname>Ethell</surname> <given-names>IM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Multiple EphB receptor tyrosine kinases shape dendritic spines in the Hippocampus</article-title><source>Journal of Cell Biology</source><volume>163</volume><fpage>1313</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1083/jcb.200306033</pub-id><pub-id pub-id-type="pmid">14691139</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henson</surname> <given-names>MA</given-names></name><name><surname>Tucker</surname> <given-names>CJ</given-names></name><name><surname>Zhao</surname> <given-names>M</given-names></name><name><surname>Dudek</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Long-term depression-associated signaling is required for an in vitro model of NMDA receptor-dependent synapse pruning</article-title><source>Neurobiology of Learning and Memory</source><volume>138</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2016.10.013</pub-id><pub-id pub-id-type="pmid">27794462</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Song</surname> <given-names>NN</given-names></name><name><surname>Lan</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Hu</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>JY</given-names></name><name><surname>Zhao</surname> <given-names>CJ</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Ding</surname> <given-names>YQ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sensory input is required for callosal axon targeting in the somatosensory cortex</article-title><source>Molecular Brain</source><volume>6</volume><elocation-id>53</elocation-id><pub-id pub-id-type="doi">10.1186/1756-6606-6-53</pub-id><pub-id pub-id-type="pmid">24305168</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huettner</surname> <given-names>JE</given-names></name><name><surname>Bean</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels</article-title><source>PNAS</source><volume>85</volume><fpage>1307</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.4.1307</pub-id><pub-id pub-id-type="pmid">2448800</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innocenti</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The target of exuberant projections in development</article-title><source>Cerebral Cortex</source><volume>30</volume><fpage>3820</fpage><lpage>3826</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhz344</pub-id><pub-id pub-id-type="pmid">31989156</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innocenti</surname> <given-names>GM</given-names></name><name><surname>Price</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Exuberance in the development of cortical networks</article-title><source>Nature Reviews Neuroscience</source><volume>6</volume><fpage>955</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1038/nrn1790</pub-id><pub-id pub-id-type="pmid">16288299</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasato</surname> <given-names>T</given-names></name><name><surname>Datwani</surname> <given-names>A</given-names></name><name><surname>Wolf</surname> <given-names>AM</given-names></name><name><surname>Nishiyama</surname> <given-names>H</given-names></name><name><surname>Taguchi</surname> <given-names>Y</given-names></name><name><surname>Tonegawa</surname> <given-names>S</given-names></name><name><surname>Knöpfel</surname> <given-names>T</given-names></name><name><surname>Erzurumlu</surname> <given-names>RS</given-names></name><name><surname>Itohara</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex</article-title><source>Nature</source><volume>406</volume><fpage>726</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1038/35021059</pub-id><pub-id pub-id-type="pmid">10963597</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kania</surname> <given-names>A</given-names></name><name><surname>Klein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mechanisms of ephrin–Eph signalling in development, physiology and disease</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>17</volume><fpage>240</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1038/nrm.2015.16</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Káradóttir</surname> <given-names>R</given-names></name><name><surname>Cavelier</surname> <given-names>P</given-names></name><name><surname>Bergersen</surname> <given-names>LH</given-names></name><name><surname>Attwell</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>NMDA receptors are expressed in oligodendrocytes and activated in ischaemia</article-title><source>Nature</source><volume>438</volume><fpage>1162</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1038/nature04302</pub-id><pub-id pub-id-type="pmid">16372011</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessels</surname> <given-names>HW</given-names></name><name><surname>Nabavi</surname> <given-names>S</given-names></name><name><surname>Malinow</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression</article-title><source>PNAS</source><volume>110</volume><fpage>4033</fpage><lpage>4038</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219605110</pub-id><pub-id pub-id-type="pmid">23431156</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khazipov</surname> <given-names>R</given-names></name><name><surname>Sirota</surname> <given-names>A</given-names></name><name><surname>Leinekugel</surname> <given-names>X</given-names></name><name><surname>Holmes</surname> <given-names>GL</given-names></name><name><surname>Ben-Ari</surname> <given-names>Y</given-names></name><name><surname>Buzsáki</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Early motor activity drives spindle bursts in the developing somatosensory cortex</article-title><source>Nature</source><volume>432</volume><fpage>758</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1038/nature03132</pub-id><pub-id pub-id-type="pmid">15592414</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khazipov</surname> <given-names>R</given-names></name><name><surname>Luhmann</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Early patterns of electrical activity in the developing cerebral cortex of humans and rodents</article-title><source>Trends in Neurosciences</source><volume>29</volume><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2006.05.007</pub-id><pub-id pub-id-type="pmid">16713634</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korotkova</surname> <given-names>T</given-names></name><name><surname>Fuchs</surname> <given-names>EC</given-names></name><name><surname>Ponomarenko</surname> <given-names>A</given-names></name><name><surname>von Engelhardt</surname> <given-names>J</given-names></name><name><surname>Monyer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory</article-title><source>Neuron</source><volume>68</volume><fpage>557</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.017</pub-id><pub-id pub-id-type="pmid">21040854</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutsuwada</surname> <given-names>T</given-names></name><name><surname>Kashiwabuchi</surname> <given-names>N</given-names></name><name><surname>Mori</surname> <given-names>H</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Kushiya</surname> <given-names>E</given-names></name><name><surname>Araki</surname> <given-names>K</given-names></name><name><surname>Meguro</surname> <given-names>H</given-names></name><name><surname>Masaki</surname> <given-names>H</given-names></name><name><surname>Kumanishi</surname> <given-names>T</given-names></name><name><surname>Arakawa</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Molecular diversity of the NMDA receptor channel</article-title><source>Nature</source><volume>358</volume><fpage>36</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/358036a0</pub-id><pub-id pub-id-type="pmid">1377365</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>CG</given-names></name><name><surname>Zukin</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders</article-title><source>Nature Reviews Neuroscience</source><volume>8</volume><fpage>413</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1038/nrn2153</pub-id><pub-id pub-id-type="pmid">17514195</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>XB</given-names></name><name><surname>Murray</surname> <given-names>KD</given-names></name><name><surname>Jones</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development</article-title><source>Journal of Neuroscience</source><volume>24</volume><fpage>8885</fpage><lpage>8895</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2476-04.2004</pub-id><pub-id pub-id-type="pmid">15470155</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>FS</given-names></name><name><surname>Akkentli</surname> <given-names>F</given-names></name><name><surname>Tsytsarev</surname> <given-names>V</given-names></name><name><surname>Erzurumlu</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Functional significance of cortical NMDA receptors in somatosensory information processing</article-title><source>Journal of Neurophysiology</source><volume>110</volume><fpage>2627</fpage><lpage>2636</lpage><pub-id pub-id-type="doi">10.1152/jn.00052.2013</pub-id><pub-id pub-id-type="pmid">24047907</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loftis</surname> <given-names>JM</given-names></name><name><surname>Janowsky</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications</article-title><source>Pharmacology &amp; Therapeutics</source><volume>97</volume><fpage>55</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/S0163-7258(02)00302-9</pub-id><pub-id pub-id-type="pmid">12493535</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>L</given-names></name><name><surname>O'Leary</surname> <given-names>DD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Axon retraction and degeneration in development and disease</article-title><source>Annual Review of Neuroscience</source><volume>28</volume><fpage>127</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.28.061604.135632</pub-id><pub-id pub-id-type="pmid">16022592</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname> <given-names>L</given-names></name><name><surname>Zwingman</surname> <given-names>TA</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Oh</surname> <given-names>SW</given-names></name><name><surname>Zariwala</surname> <given-names>HA</given-names></name><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>LL</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milton</surname> <given-names>AL</given-names></name><name><surname>Lee</surname> <given-names>JL</given-names></name><name><surname>Butler</surname> <given-names>VJ</given-names></name><name><surname>Gardner</surname> <given-names>R</given-names></name><name><surname>Everitt</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drug-seeking behaviors</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>8230</fpage><lpage>8237</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1723-08.2008</pub-id><pub-id pub-id-type="pmid">18701685</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitrovic</surname> <given-names>N</given-names></name><name><surname>Mohajeri</surname> <given-names>H</given-names></name><name><surname>Schachner</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Effects of NMDA receptor blockade in the developing rat somatosensory cortex on the expression of the glia-derived extracellular matrix glycoprotein tenascin-C</article-title><source>European Journal of Neuroscience</source><volume>8</volume><fpage>1793</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.1996.tb01323.x</pub-id><pub-id pub-id-type="pmid">8921270</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname> <given-names>H</given-names></name><name><surname>Hirano</surname> <given-names>T</given-names></name><name><surname>Tagawa</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Evidence for activity-dependent cortical wiring: formation of interhemispheric connections in neonatal mouse visual cortex requires projection neuron activity</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>6760</fpage><lpage>6770</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1215-07.2007</pub-id><pub-id pub-id-type="pmid">17581963</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monyer</surname> <given-names>H</given-names></name><name><surname>Burnashev</surname> <given-names>N</given-names></name><name><surname>Laurie</surname> <given-names>DJ</given-names></name><name><surname>Sakmann</surname> <given-names>B</given-names></name><name><surname>Seeburg</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</article-title><source>Neuron</source><volume>12</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(94)90210-0</pub-id><pub-id pub-id-type="pmid">7512349</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5</article-title><source>The Journal of Neuroscience</source><volume>9</volume><fpage>3040</fpage><lpage>3057</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.09-09-03040.1989</pub-id><pub-id pub-id-type="pmid">2552039</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>B</given-names></name><name><surname>Yuan</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>NMDA receptors in mouse anterior piriform cortex initialize early odor preference learning and L-type calcium channels engage for long-term memory</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>35256</elocation-id><pub-id pub-id-type="doi">10.1038/srep35256</pub-id><pub-id pub-id-type="pmid">27739540</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabavi</surname> <given-names>S</given-names></name><name><surname>Kessels</surname> <given-names>HW</given-names></name><name><surname>Alfonso</surname> <given-names>S</given-names></name><name><surname>Aow</surname> <given-names>J</given-names></name><name><surname>Fox</surname> <given-names>R</given-names></name><name><surname>Malinow</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression</article-title><source>PNAS</source><volume>110</volume><fpage>4027</fpage><lpage>4032</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219454110</pub-id><pub-id pub-id-type="pmid">23431133</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niethamer</surname> <given-names>TK</given-names></name><name><surname>Bush</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Getting direction(s): The Eph/ephrin signaling system in cell positioning</article-title><source>Developmental Biology</source><volume>447</volume><fpage>42</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.01.012</pub-id><pub-id pub-id-type="pmid">29360434</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname> <given-names>M</given-names></name><name><surname>Carlsson</surname> <given-names>A</given-names></name><name><surname>Carlsson</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Glycine and D-serine decrease MK-801-induced hyperactivity in mice</article-title><source>Journal of Neural Transmission</source><volume>104</volume><fpage>1195</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1007/BF01294720</pub-id><pub-id pub-id-type="pmid">9503265</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolt</surname> <given-names>MJ</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Hruska</surname> <given-names>M</given-names></name><name><surname>Murphy</surname> <given-names>J</given-names></name><name><surname>Sheffler-Colins</surname> <given-names>SI</given-names></name><name><surname>Kayser</surname> <given-names>MS</given-names></name><name><surname>Passer</surname> <given-names>J</given-names></name><name><surname>Bennett</surname> <given-names>MV</given-names></name><name><surname>Zukin</surname> <given-names>RS</given-names></name><name><surname>Dalva</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>5353</fpage><lpage>5364</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0282-11.2011</pub-id><pub-id pub-id-type="pmid">21471370</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orioli</surname> <given-names>D</given-names></name><name><surname>Henkemeyer</surname> <given-names>M</given-names></name><name><surname>Lemke</surname> <given-names>G</given-names></name><name><surname>Klein</surname> <given-names>R</given-names></name><name><surname>Pawson</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Sek4 and nuk receptors cooperate in guidance of commissural axons and in palate formation</article-title><source>The EMBO Journal</source><volume>15</volume><fpage>6035</fpage><lpage>6049</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1996.tb00992.x</pub-id><pub-id pub-id-type="pmid">8947026</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname> <given-names>A</given-names></name><name><surname>Klein</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Multiple roles of ephrins in Morphogenesis, neuronal networking, and brain function</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>1429</fpage><lpage>1450</lpage><pub-id pub-id-type="doi">10.1101/gad.1093703</pub-id><pub-id pub-id-type="pmid">12815065</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paoletti</surname> <given-names>P</given-names></name><name><surname>Bellone</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</article-title><source>Nature Reviews Neuroscience</source><volume>14</volume><fpage>383</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/nrn3504</pub-id><pub-id pub-id-type="pmid">23686171</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname> <given-names>LK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement</article-title><source>Journal of Neurodevelopmental Disorders</source><volume>3</volume><fpage>3</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1007/s11689-010-9059-y</pub-id><pub-id pub-id-type="pmid">21484594</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Personius</surname> <given-names>KE</given-names></name><name><surname>Slusher</surname> <given-names>BS</given-names></name><name><surname>Udin</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neuromuscular NMDA receptors modulate developmental synapse elimination</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>8783</fpage><lpage>8789</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1181-16.2016</pub-id><pub-id pub-id-type="pmid">27559162</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabacchi</surname> <given-names>S</given-names></name><name><surname>Bailly</surname> <given-names>Y</given-names></name><name><surname>Delhaye-Bouchaud</surname> <given-names>N</given-names></name><name><surname>Mariani</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Involvement of the N-methyl D-aspartate (NMDA) receptor in synapse elimination during cerebellar development</article-title><source>Science</source><volume>256</volume><fpage>1823</fpage><lpage>1825</lpage><pub-id pub-id-type="doi">10.1126/science.1352066</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname> <given-names>I</given-names></name><name><surname>Witte</surname> <given-names>S</given-names></name><name><surname>Cline</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>NMDA receptor activity stabilizes presynaptic retinotectal axons and postsynaptic optic tectal cell dendrites in vivo</article-title><source>Journal of Neurobiology</source><volume>38</volume><fpage>357</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4695(19990215)38:3&lt;357::AID-NEU5&gt;3.0.CO;2-#</pub-id><pub-id pub-id-type="pmid">10022578</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro Gomes</surname> <given-names>AR</given-names></name><name><surname>Olivier</surname> <given-names>E</given-names></name><name><surname>Killackey</surname> <given-names>HP</given-names></name><name><surname>Giroud</surname> <given-names>P</given-names></name><name><surname>Berland</surname> <given-names>M</given-names></name><name><surname>Knoblauch</surname> <given-names>K</given-names></name><name><surname>Dehay</surname> <given-names>C</given-names></name><name><surname>Kennedy</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Refinement of the primate corticospinal pathway during prenatal development</article-title><source>Cerebral Cortex</source><volume>30</volume><fpage>656</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhz116</pub-id><pub-id pub-id-type="pmid">31343065</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robichaux</surname> <given-names>MA</given-names></name><name><surname>Chenaux</surname> <given-names>G</given-names></name><name><surname>Ho</surname> <given-names>HY</given-names></name><name><surname>Soskis</surname> <given-names>MJ</given-names></name><name><surname>Greenberg</surname> <given-names>ME</given-names></name><name><surname>Henkemeyer</surname> <given-names>M</given-names></name><name><surname>Cowan</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>EphB1 and EphB2 intracellular domains regulate the formation of the corpus callosum and anterior commissure</article-title><source>Developmental Neurobiology</source><volume>76</volume><fpage>405</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1002/dneu.22323</pub-id><pub-id pub-id-type="pmid">26148571</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Tornos</surname> <given-names>FM</given-names></name><name><surname>Briz</surname> <given-names>CG</given-names></name><name><surname>Weiss</surname> <given-names>LA</given-names></name><name><surname>Sebastián-Serrano</surname> <given-names>A</given-names></name><name><surname>Ares</surname> <given-names>S</given-names></name><name><surname>Navarrete</surname> <given-names>M</given-names></name><name><surname>Frangeul</surname> <given-names>L</given-names></name><name><surname>Galazo</surname> <given-names>M</given-names></name><name><surname>Jabaudon</surname> <given-names>D</given-names></name><name><surname>Esteban</surname> <given-names>JA</given-names></name><name><surname>Nieto</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cux1 enables interhemispheric connections of layer II/III neurons by regulating Kv1-Dependent firing</article-title><source>Neuron</source><volume>89</volume><fpage>494</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.12.020</pub-id><pub-id pub-id-type="pmid">26804994</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruthazer</surname> <given-names>ES</given-names></name><name><surname>Akerman</surname> <given-names>CJ</given-names></name><name><surname>Cline</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Control of axon branch dynamics by correlated activity in vivo</article-title><source>Science</source><volume>301</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1126/science.1082545</pub-id><pub-id pub-id-type="pmid">12843386</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sans</surname> <given-names>NA</given-names></name><name><surname>Montcouquiol</surname> <given-names>ME</given-names></name><name><surname>Raymond</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Postnatal developmental changes in AMPA and NMDA receptors in the rat vestibular nuclei</article-title><source>Developmental Brain Research</source><volume>123</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/S0165-3806(00)00082-1</pub-id><pub-id pub-id-type="pmid">11020549</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheffler-Collins</surname> <given-names>SI</given-names></name><name><surname>Dalva</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>EphBs: an integral link between synaptic function and synaptopathies</article-title><source>Trends in Neurosciences</source><volume>35</volume><fpage>293</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2012.03.003</pub-id><pub-id pub-id-type="pmid">22516618</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>M</given-names></name><name><surname>Cummings</surname> <given-names>J</given-names></name><name><surname>Roldan</surname> <given-names>LA</given-names></name><name><surname>Jan</surname> <given-names>YN</given-names></name><name><surname>Jan</surname> <given-names>LY</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Changing subunit composition of heteromeric NMDA receptors during development of rat cortex</article-title><source>Nature</source><volume>368</volume><fpage>144</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1038/368144a0</pub-id><pub-id pub-id-type="pmid">8139656</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suárez</surname> <given-names>R</given-names></name><name><surname>Fenlon</surname> <given-names>LR</given-names></name><name><surname>Marek</surname> <given-names>R</given-names></name><name><surname>Avitan</surname> <given-names>L</given-names></name><name><surname>Sah</surname> <given-names>P</given-names></name><name><surname>Goodhill</surname> <given-names>GJ</given-names></name><name><surname>Richards</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Balanced interhemispheric cortical activity is required for correct targeting of the corpus callosum</article-title><source>Neuron</source><volume>82</volume><fpage>1289</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.04.040</pub-id><pub-id pub-id-type="pmid">24945772</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takasu</surname> <given-names>MA</given-names></name><name><surname>Dalva</surname> <given-names>MB</given-names></name><name><surname>Zigmond</surname> <given-names>RE</given-names></name><name><surname>Greenberg</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors</article-title><source>Science</source><volume>295</volume><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1126/science.1065983</pub-id><pub-id pub-id-type="pmid">11799243</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traynelis</surname> <given-names>SF</given-names></name><name><surname>Wollmuth</surname> <given-names>LP</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name><name><surname>Menniti</surname> <given-names>FS</given-names></name><name><surname>Vance</surname> <given-names>KM</given-names></name><name><surname>Ogden</surname> <given-names>KK</given-names></name><name><surname>Hansen</surname> <given-names>KB</given-names></name><name><surname>Yuan</surname> <given-names>H</given-names></name><name><surname>Myers</surname> <given-names>SJ</given-names></name><name><surname>Dingledine</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Glutamate receptor ion channels: structure, regulation, and function</article-title><source>Pharmacological Reviews</source><volume>62</volume><fpage>405</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1124/pr.109.002451</pub-id><pub-id pub-id-type="pmid">20716669</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uttl</surname> <given-names>L</given-names></name><name><surname>Petrasek</surname> <given-names>T</given-names></name><name><surname>Sengul</surname> <given-names>H</given-names></name><name><surname>Svojanovska</surname> <given-names>M</given-names></name><name><surname>Lobellova</surname> <given-names>V</given-names></name><name><surname>Vales</surname> <given-names>K</given-names></name><name><surname>Radostova</surname> <given-names>D</given-names></name><name><surname>Tsenov</surname> <given-names>G</given-names></name><name><surname>Kubova</surname> <given-names>H</given-names></name><name><surname>Mikulecka</surname> <given-names>A</given-names></name><name><surname>Svoboda</surname> <given-names>J</given-names></name><name><surname>Stuchlik</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chronic MK-801 application in adolescence and early adulthood: a spatial working memory deficit in adult Long-Evans rats but no changes in the hippocampal NMDA receptor subunits</article-title><source>Frontiers in Pharmacology</source><volume>9</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00042</pub-id><pub-id pub-id-type="pmid">29487522</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vearing</surname> <given-names>CJ</given-names></name><name><surname>Lackmann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>&quot;Eph receptor signalling; dimerisation just isn't enough&quot;</article-title><source>Growth Factors</source><volume>23</volume><fpage>67</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1080/08977190500055869</pub-id><pub-id pub-id-type="pmid">16019428</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissel</surname> <given-names>B</given-names></name><name><surname>Krupp</surname> <given-names>JJ</given-names></name><name><surname>Heinemann</surname> <given-names>SF</given-names></name><name><surname>Westbrook</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux</article-title><source>Nature Neuroscience</source><volume>4</volume><fpage>587</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1038/88404</pub-id><pub-id pub-id-type="pmid">11369939</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname> <given-names>D</given-names></name><name><surname>Wu</surname> <given-names>P-R</given-names></name><name><surname>Sorrells</surname> <given-names>SF</given-names></name><name><surname>Arnold</surname> <given-names>C</given-names></name><name><surname>Alvarez-Buylla</surname> <given-names>A</given-names></name><name><surname>Rubenstein</surname> <given-names>JLR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Viral-mediated labeling and transplantation of medial ganglionic eminence (MGE) Cells for in vivo studies</article-title><source>Journal of Visualized Experiments</source><volume>98</volume><elocation-id>52740</elocation-id><pub-id pub-id-type="doi">10.3791/52740</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>CL</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>XJ</given-names></name><name><surname>Duan</surname> <given-names>SM</given-names></name><name><surname>Xiong</surname> <given-names>ZQ</given-names></name><name><surname>Ding</surname> <given-names>YQ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Activity-dependent development of callosal projections in the somatosensory cortex</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>11334</fpage><lpage>11342</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3380-07.2007</pub-id><pub-id pub-id-type="pmid">17942728</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weilinger</surname> <given-names>NL</given-names></name><name><surname>Lohman</surname> <given-names>AW</given-names></name><name><surname>Rakai</surname> <given-names>BD</given-names></name><name><surname>Ma</surname> <given-names>EM</given-names></name><name><surname>Bialecki</surname> <given-names>J</given-names></name><name><surname>Maslieieva</surname> <given-names>V</given-names></name><name><surname>Rilea</surname> <given-names>T</given-names></name><name><surname>Bandet</surname> <given-names>MV</given-names></name><name><surname>Ikuta</surname> <given-names>NT</given-names></name><name><surname>Scott</surname> <given-names>L</given-names></name><name><surname>Colicos</surname> <given-names>MA</given-names></name><name><surname>Teskey</surname> <given-names>GC</given-names></name><name><surname>Winship</surname> <given-names>IR</given-names></name><name><surname>Thompson</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabotropic NMDA receptor signaling couples src family kinases to pannexin-1 during excitotoxicity</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>432</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/nn.4236</pub-id><pub-id pub-id-type="pmid">26854804</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Zou</surname> <given-names>H</given-names></name><name><surname>Strong</surname> <given-names>JA</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Xie</surname> <given-names>Q</given-names></name><name><surname>Zhao</surname> <given-names>G</given-names></name><name><surname>Jin</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice</article-title><source>Psychopharmacology</source><volume>177</volume><fpage>256</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1007/s00213-004-1944-1</pub-id><pub-id pub-id-type="pmid">15290006</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>NJ</given-names></name><name><surname>Henkemeyer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1038/nn.2254</pub-id><pub-id pub-id-type="pmid">19182796</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabut</surname> <given-names>OR</given-names></name><name><surname>Fernandez</surname> <given-names>G</given-names></name><name><surname>Huynh</surname> <given-names>T</given-names></name><name><surname>Yoon</surname> <given-names>K</given-names></name><name><surname>Pleasure</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Suppressor of fused is critical for maintenance of neuronal progenitor identity during corticogenesis</article-title><source>Cell Reports</source><volume>12</volume><fpage>2021</fpage><lpage>2034</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.031</pub-id><pub-id pub-id-type="pmid">26387942</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>JW</given-names></name><name><surname>Hanganu-Opatz</surname> <given-names>IL</given-names></name><name><surname>Sun</surname> <given-names>JJ</given-names></name><name><surname>Luhmann</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Three patterns of oscillatory activity differentially synchronize developing neocortical networks in vivo</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>9011</fpage><lpage>9025</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5646-08.2009</pub-id><pub-id pub-id-type="pmid">19605639</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>ZW</given-names></name><name><surname>Peterson</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Essential role of postsynaptic NMDA receptors in developmental refinement of excitatory synapses</article-title><source>PNAS</source><volume>110</volume><fpage>1095</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1073/pnas.1212971110</pub-id><pub-id pub-id-type="pmid">23277569</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Wen</surname> <given-names>Y</given-names></name><name><surname>She</surname> <given-names>L</given-names></name><name><surname>Sui</surname> <given-names>YN</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Richards</surname> <given-names>LJ</given-names></name><name><surname>Poo</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Axon position within the corpus callosum determines contralateral cortical projection</article-title><source>PNAS</source><volume>110</volume><fpage>E2714</fpage><lpage>E2723</lpage><pub-id pub-id-type="doi">10.1073/pnas.1310233110</pub-id><pub-id pub-id-type="pmid">23812756</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname> <given-names>DY</given-names></name><name><surname>Zhang</surname> <given-names>YH</given-names></name><name><surname>Cao</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>CF</given-names></name><name><surname>Tanaka</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>YL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior</article-title><source>Life Sciences</source><volume>78</volume><fpage>2172</fpage><lpage>2178</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.09.022</pub-id><pub-id pub-id-type="pmid">16280137</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59612.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Mason</surname><given-names>Carol A</given-names></name><role>Reviewing Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Your paper highlights a novel mechanism for the development of callosal projections from primary somatosensory cortex (S1), through demonstrating that the normal termination pattern of callosal projections are disrupted in cortex-specific NMDAR mutants. Rather than projecting selectively to the primary/secondary somatosensory cortex (S1/S2) border, axons are uniformly distributed throughout S1, with this pattern intensifying until a premature death. You also suggest that GluN2B-containing NMDA receptors mediate this phenotype during callosal innervation of somatosensory cortex and is independent of ion channel function. Finally, you propose that NMDAR functions with the ephrinB/EphB system of guidance molecules.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;NMDA receptors control cortical axonal projections via EPHRIN-B/EPHB signaling&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jonathan Cooper as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>Your study points to a novel mechanism for the development of callosal projections from primary somatosensory cortex (S1), namely, that NR2B-containing NMDA receptors are required to mediate the normal termination pattern of callosal projections. You also show that NR2B-containing NMDAR during callosal innervation of somatosensory cortex is independent of ion channel function in these receptors. An additional, novel slant is your proposal that NMDARs act as accessory axon guidance molecules via Eph/ephrin repulsion. You pose a model where these well-studied axon guidance molecules interact directly with the NMDAR, to coordinate the formation of axonal projections, again, indicating non-ionotrophic functions of the NMDAR.</p><p>From the appended reviews, you will see that the reviewers thought that the claims in the manuscript for the NR2B-containing NMDAR function during callosal innervation are well supported. However, all three reviewers questioned the link between the ephrin/Eph system and NMDAR function, and considered the analyses related to this link preliminary. They thought that this aspect should be strengthened, either through additional experiments (in vitro tests of repellent activity) or by toning down the discussion and potentially removing the link to ephrinB/EphB signaling from the title and Abstract. While it may not be possible to do the additional suggested experiments since lab shutdown and restarting, the revisions on data presentation and textually in the discussion are feasible and could be done in the coming months.</p><p>Revisions for this paper:</p><p>For the glutamate receptor data:</p><p>1) In the GluN2A and GluN2B floxed mice: at the ages studied, it is unclear how much GluN2A is expressed.</p><p>2) With MK801 and APV application to block the NMDAR, how effective are these drugs at blocking the NMDAR and what is the area of effect of the drugs? Are other activity-dependent events blocked in these animals (e.g., LGN lamination, whisker barrelette formation in PrV)?</p><p>The drugs blocking NMDAR activity lack sufficient controls for the conclusions stated in the manuscript: Loss of the innervation pattern of innervation is variable and the S1/S2 column indicates a possible dependency on activity, leading to other possible interpretations. Changes in the overall cortical activity may affect the stabilization of callosal projections, and therefore acute pharmacological blocking of NMDAR may not mimic the KO or antibody treatments. Early and permanent loss of NMDAR activity can trigger changes in the intrinsic excitability of the neurons that could override the phenotypes of increased innervation. This could be discussed textually</p><p>For the Eph/ephrin data:</p><p>3) You argue EphB2 protein levels are reduced in the cortex of conditional NR1 floxed mice and disruption of ephrin-B/EphB signaling in this system leads to similar termination defects as deleting NR2B. This is an apt argument but the reviewers felt that this was only a first step in the required analyses.</p><p><italic>Reviewer #3:</italic></p><p>4) Figure 8. By Western blot analysis, the reduction seems 30% compared to controls. This is not dramatic and instead suggests other mechanisms at work, since most heterozygous mutants (with target protein reductions at 50% or more) do not show phenotypes.</p><p>5) Partial reduction of EphB2 protein raises the possibility that further reductions of EphB2 signaling may enhance the phenotype. Instead, blocking NMDAR plus EphB2 functions (by injecting NR1Ab and ephrin-B1-Fc) did not enhance the phenotype of the single manipulations. One would expect additive effects.</p><p>6) Figure 8, only the timepoint P6 is shown. Rev 5 also points out that between P6 and P10 there is more variability in contralateral innervation correlating with the anterior-posterior axis. You should show ephrin B electroporations analyzed at P14-P30, or remove and/or tone down the text.</p><p><italic>Reviewer #4:</italic></p><p>7) EphB-ephrin-B signaling and NMDAR function likely has to do with EphB-ephrin-B repulsive cues or that EphBs interact and modulate NMDAR function, and regulate excitatory synapse development in forebrain. It seems at least equally likely that in the latter case, EphB modulation of NMDAR may mediate the events described in this manuscript, on synapse development and maintenance, not necessarily on repulsion/guidance.</p><p>8) EphB-NMDAR interaction results in phosphorylation of GluN2B, increased synaptic localization of the NMDAR, and increased NMDAR dependent Ca influx. Loss of EphB-ephrin-B signaling might cause a reduction in NMDAR Ca influx, but not a complete block of ionotropic signaling. To demonstrate that the findings in Figures 7 and 8 are linked, the authors should inject NMDAR blockers (after conducting the control experiments in point 2), in the ephrin-B1 knockout mice. The anti-NMDAR antibodies simply remove the receptor from the synapse. This does not address whether the effects are independent of the ionotropic modulation of the channel and should be discussed.</p><p>Revisions expected in follow-up work:</p><p>1) In implicating repellent activity that would restrict commissural axonal projections to the S1 cortex, the evidence for NMDAR via Eph B2 function as repellents for elongating callosal axons is lacking. in vitro experiments demonstrating repellent activity of EphB downstream of NMDAR would be necessary to make this claim. Given the time required to develop and execute such an assay, and the pandemic delays, you could take as long as needed to do this experiment, if you choose to do so.</p><p>2) Reviewers 4 and 5 point out that these pathways could be involved in refinement and pruning of axons: Reviewer 5 raises the possibility that in the mutants, axons are stabilized, to result in extra numbers of callosal neurons. NMDAR could thus be responsible for repulsion during refinement. Reviewer 4's comments on EphBs interacting with excitatory synapse development could play into this explanation. More high-resolution analysis of the impact of your manipulations on axonal branching would address the other reviewers' questions regarding whether the changes see are due defects in branching and/or refinement. This aspect as in the in vitro experiments require additional experiments which could understandably not be possible at this time.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for submitting your article &quot;NMDA receptors control development of somatosensory callosal axonal projections&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jonathan Cooper as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>Summary:</p><p>Your revision highlights a novel mechanism for the development of callosal projections from primary somatosensory cortex (S1), through demonstrating that the normal termination pattern of callosal projections are disrupted in cortex-specific NMDAR mutants. Rather than projecting selectively to the primary/secondary somatosensory cortex (S1/S2) border, axons are uniformly distributed throughout S1, with this pattern intensifying until a premature death. You also suggest that GluN2B-containing NMDA receptors mediate this phenotype during callosal innervation of somatosensory cortex and is independent of ion channel function. Finally, you propose that NMDAR functions with the ephrinB/EphB system of guidance molecules.</p><p>Due to constraints put in place by COVID, in many cases you have had to reduce the strength of your claims rather than conduct new experiments, and you have satisfactorily downplayed the link between the ephrin/Eph system and NMDAR function. While you were not able to directly show that the NMDAR blockers used were effective at blocking NMDAR channel function, the demonstration of a potential link between activity-independent and activity-dependent signaling systems to impact axon development is considered exciting and novel.</p><p>The previous review stated that you could look to performing follow-up work in the future on: (a). in vitro experiments demonstrating repellent activity of EphB downstream of NMDAR to fortify the link between EphB and NMDAR expression levels. (b). experiments to show the effects of inhibiting Eph/ephrin signaling at later time points, especially on examining refinement and pruning of axons. We hope you will be able to pursue these interesting studies when conditions improve.</p><p>Revisions:</p><p>The rebuttal letter was difficult to follow. It was not clear where in the manuscript some of the changes were made. Figures were not labelled and main figures were mixed with supplementary figures. However, the following points appear not to have been addressed adequately:</p><p>1) In response to the criticism of overstating the 30% reduction in EphB2 protein expression in the Grin1 CKOs, the authors have provided images showing EphB2 immunofluorescence in Emx1Cre;Grin1fl/fl;tdTomato mice (Figure 8—figure supplement 2). While the pictures in this new figure suggest loss of EphB2 IF in Tom+;Grin1 cKO cells, but not in Tom+;control cells, the results should be quantified. Presenting images without quantification is not convincing. Please quantify and add the results to the paper.</p><p>2) Please address the following points that were raised in the previous critique and appear not to have been answered:</p><p>a) show images of all controls and experimental groups of Figure 3 in Supplementary data.</p><p>b) Provide better evidence for NR1 protein downregulation in the conditional NR1 knockouts (Figure 1—figure supplement 1).</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.59612.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Revisions for this paper:</p><p>For the glutamate receptor data:</p><p>1) In the GluN2A and GluN2B floxed mice: at the ages studied, it is unclear how much GluN2A is expressed.</p></disp-quote><p>We have performed western blot of S1 at P8 and found GluN2A is expressed at P8. We have added “To address previous studies that found that GluN2A was expressed at lower levels during development we checked the expression of GluN2A in S1 at P8, and found that it was dramatically diminished in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2A<sup>fl/fl</sup></italic> mice (Figure 6—figure supplement 2A, 2B). While the expression of GluN2B was the same in control and <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2A<sup>fl/fl</sup></italic> mice (Figure 6—figure supplement 2A, 2C), and similarly GluN2A expression was unchanged in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin2B<sup>fl/fl</sup></italic> mice (Data not shown)” to the text when mentioned about “GluN2B, but not GluN2A, is required for callosal axon targeting”.</p><disp-quote content-type="editor-comment"><p>2) With MK801 and APV application to block the NMDAR, how effective are these drugs at blocking the NMDAR and what is the area of effect of the drugs? Are other activity-dependent events blocked in these animals (e.g., LGN lamination, whisker barrelette formation in PrV)?</p></disp-quote><p>We agree with these points raised by the reviewer. These were the exactly concerns we had when we began the experiments. We consulted local electrophysiology labs who suggested we use (+)-MK-801 hydrogen maleate and D(-)-2-amino-5-phosphonopentanoic acid (D-APV) which are most the effective isoforms for in vivo studies. We also carefully examined the previous literature to determine the dosage range for chronic treatment studies and tested on our own to find the optimal dosage (see the details in Materials and methods). Based on the literature, weight loss and abnormal behavior have been reported in neonatal mice after MK-801 administration (Facchinetti et al., 1993; Griesbach and Amsel, 1998; Wu et al., 2005) which can be used as a sign of effective MK-801 administration. We also found weight loss and abnormal behaviors after systemic i.p. MK-801 administration in mouse pups. For local D-APV injection, we did not see weight loss for pups but did see abnormal behaviors after injection.</p><p>We searched the original literature to address the question “Are other activity-dependent events blocked in these animals (e.g., LGN lamination, whisker barrelette formation in PrV)?” For the LGN, we calculated that the dose used for ferret pups was 0.4mg/kg MK-801 daily. Our dose was 1mg/kg MK-801 daily which is significantly higher than the published dose. It further suggested our dose is effective in mouse pups. So we add this sentence of “Previous studies showed that blocking NMDAR with a daily dose of 0.4mg/kg MK-801 in ferret pups between P14 and P21 disrupted axonal pattern formation by retinal afferents in the lateral geniculate nucleus (LGN) (Hahm et al., 1999)” in the text when mentioned about “NMDAR regulates callosal circuit development independent of NMDAR channel activity”. For PrV (Mitrovic et al., 1996), they used silicone carriers to locally apply MK-801 and D-APV, it was not clear how much MK-801 and APPV were delivered to the targeted tissue.</p><p>Of course, the most direct way to test whether our MK-801 or D-APV in vivo administration blocked or reduced Ca<sup>2+</sup> influx of NMDAR, is doing calcium imaging or electrical recording on brain slides after acute and chronic MK-801 or D-APV administration. However, during the pandemic of COVID-19, it is difficult to extend our studies to perform this experiment currently, however, we believe the literature is fairly clear that our treatments are surely affecting NMDAR function profoundly. We do plan to pursue experiments like this in the future.</p><disp-quote content-type="editor-comment"><p>The drugs blocking NMDAR activity lack sufficient controls for the conclusions stated in the manuscript: Loss of the innervation pattern of innervation is variable and the S1/S2 column indicates a possible dependency on activity, leading to other possible interpretations. Changes in the overall cortical activity may affect the stabilization of callosal projections, and therefore acute pharmacological blocking of NMDAR may not mimic the KO or antibody treatments. Early and permanent loss of NMDAR activity can trigger changes in the intrinsic excitability of the neurons that could override the phenotypes of increased innervation. This could be discussed textually</p></disp-quote><p>We agree and appreciate the valuable advice. In the newly edited manuscript, we disused these possibilities in our Discussion “Previous studies have observed the role of NMDAR in axon elimination (Colonnese and Constantine-Paton, 2006; Henson et al., 2017; Personius et al., 2016; Rabacchi et al., 1992; Rajan et al., 1999; Zhang et al., 2013). in vivo time-lapse images of retinal axons from albino <italic>Xenopus</italic> tadpoles show that correlated neural activity influences axon branch dynamics of retinal axons in the optic tectum (Ruthazer et al., 2003). The axon branches whose activity is not correlated with that of their neighbors are selectively eliminated. However, the selective elimination can be abolished by blocking the Ca<sup>2+</sup> influx of NMDAR by its antagonist MK-801. When we blocked the Ca<sup>2+</sup> influx of NMDAR by MK-801 or D-APV, even though the overall callosal innervation pattern of somatosensory cortex was not affected, there were some subtle, local laminar-specific innervation differences at the S1/S2 border, suggesting that the refinement of axon arborization may rely on the Ca<sup>2+</sup> influx-mediated activity changes through NMDAR” when mentioned about “The refinement of callosal innervation pattern”.</p><disp-quote content-type="editor-comment"><p>For the Eph/ephrin data:</p><p>3) You argue EphB2 protein levels are reduced in the cortex of conditional NR1 floxed mice and disruption of ephrin-B/EphB signaling in this system leads to similar termination defects as deleting NR2B. This is an apt argument but the reviewers felt that this was only a first step in the required analyses.</p></disp-quote><p>We have toned down the linkage between NMDAR and EPHRINB/EPHB in the Abstract, the Results and the Discussion. We also removed the linkage between NMDAR and EPHRINB/EPHB in the title. We will examine how and whether NMDAR regulates EPHRIN-B/EPHB signaling directly and the detailed molecular mechanism underlying their collaboration to regulate callosal innervation patterns in the primary somatosensory cortex in a following project.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>4) Figure 8. By Western blot analysis, the reduction seems 30% compared to controls. This is not dramatic and instead suggests other mechanisms at work, since most heterozygous mutants (with target protein reductions at 50% or more) do not show phenotypes.</p><p>5) Partial reduction of EphB2 protein raises the possibility that further reductions of EphB2 signaling may enhance the phenotype. Instead, blocking NMDAR plus EphB2 functions (by injecting NR1Ab and ephrin-B1-Fc) did not enhance the phenotype of the single manipulations. One would expect additive effects.</p></disp-quote><p>Questions 4 and 5 are interlinked, so we are addressing them together. We understand the reviewer’s concern that a 30% reduction of EPHB2 in S1 of <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice by western blot was not dramatic. However, implicit in our studies was our assumption that the loss of EPHB2 would be selective for neurons that lost NMDAR and that this was a subset of cortical neurons. Also, we assumed that EPHB2 expressed in other compartments than the PSD might not be decreased. Thus, we believe that a 30% decrease is actually quite dramatic if the loss is limited to the PSD. We appreciate the reviewer asking us to more directly address this! <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice only knocked out GluN1 in <italic>Emx1<sup>cre/+</sup></italic> positive cells which were only a subpopulation cells in the cortex (excitatory neurons with Cre penetrance). We found that there are still many cells expressiong GluN1 in <italic>Emx1<sup>cre/+</sup></italic> unaffected cell populations, such as interneurons (Figure 1—figure supplement 1). Also, to more specifically examine the expression of EPHB2 on <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> positive cells, we crossed <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice with Cre reporter mice-<italic>Rosa26&lt;fs-tdTomato<sup>fl/fl</sup></italic> mice to generate <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup>; Rosa26&lt;fs-tdTomato<sup>fl/fl</sup> </italic>mice. We found the expression of EPHB2 was completely gone from somatic post-synaptic densities on <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup>; Rosa26&lt;fs-tdTomato<sup>fl/fl</sup> </italic>positive cells. Thus, we believe that a loss of 30% of total EPHB2 protein in the cortex is actually quite dramatic. Importantly, this can’t be compared to EPHB2+/- mice where presumably any lost protein would be distributed throughout all domains and in all cells where the protein is expressed.</p><p>We also add the following paragraph into the newly edited text “As discussed above, in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice, GluN1 was selectively deleted in excitatory neurons. Based on previous studies, the expression of GluN1 in interneurons (Korotkova et al., 2010), oligodendrocytes and oligodendrocyte precursor cells (Karadottir et al., 2005) in the cortex should not be affected in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup> </italic>mice. To examine the expression of EPHB2 specifically in GluN1 KO cells, we crossed <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup> </italic>mice with Cre-reporter mice – <italic>Rosa26&lt;fs-tdTomato<sup>fl/fl</sup> </italic>mice that exhibit tdTomato expression after Cre-mediated recombination. Supporting our hypothesis that loss of GluN1 leads to loss of EPHB2, the punctate staining of EPHB2 on cell membranes was completely lost in red (recombined) cells of <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic>; <italic>Rosa26&lt;fs-tdTomato<sup>fl/fl</sup></italic> brain sections but not red cells of <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>wt/wt</sup>;Rosa26&lt;fs-tdTomato<sup>fl/fl</sup></italic> brain sections (Figure 8—figure supplement 2). Taken together, we demonstrated that the loss of NMDAR caused the loss of EPHB2 selectively on cells that lack GluN1 after excision, thus explaining the 30% reduction in EPHB2 protein expression. Given the known physical association between NMDAR and EPHB2, these data suggest reciprocity in this stabilizing interaction and dendritic localization” when mentioned about “EPHB2 protein expression is decreased in GluN1 KO mice”.</p><disp-quote content-type="editor-comment"><p>6) Figure 8, only the timepoint P6 is shown. Rev 5 also points out that between P6 and P10 there is more variability in contralateral innervation correlating with the anterior-posterior axis. You should show ephrin B electroporations analyzed at P14-P30, or remove and/or tone down the text.</p></disp-quote><p>We have toned down the discussion of the interaction between NMDAR and EPHRINB/EPHB.</p><disp-quote content-type="editor-comment"><p>Reviewer #4:</p><p>7) EphB-ephrin-B signaling and NMDAR function likely has to do with EphB-ephrin-B repulsive cues or that EphBs interact and modulate NMDAR function, and regulate excitatory synapse development in forebrain. It seems at least equally likely that in the latter case, EphB modulation of NMDAR may mediate the events described in this manuscript, on synapse development and maintenance, not necessarily on repulsion/guidance.</p></disp-quote><p>We agree and thank the reviewer for these suggestions. We have discussed these alternative possibilities in the newly edited manuscript. We have added the following paragraph into our Discussion “Regarding previous roles of EPHRIN-B/EPHB signaling in pruning, this pathway was previous shown to be involved in infrapyramidal bundle pruning in dentate gyrus (Xu and Henkemeyer, 2009) and it is know that activation of EPHB by EPHRIN-B potentiates Ca<sup>2+</sup> influx of NMDA receptor (Takasu et al., 2002). These lines of evidence suggest that NMDAR and EPHRIN-B/EPHB signaling may cooperate in the refinement of the callosal innervation pattern and perhaps in other circuits. Further studies will examine how and whether NMDAR regulates EPHRIN-B/EPHB signaling directly and the detailed molecular mechanism underlying their collaboration to regulate callosal innervation patterns in the primary somatosensory cortex” when discussed “the refinement of callosal innervation pattern”.</p><disp-quote content-type="editor-comment"><p>8) EphB-NMDAR interaction results in phosphorylation of GluN2B, increased synaptic localization of the NMDAR, and increased NMDAR dependent Ca influx. Loss of EphB-ephrin-B signaling might cause a reduction in NMDAR Ca influx, but not a complete block of ionotropic signaling. To demonstrate that the findings in Figures 7 and 8 are linked, the authors should inject NMDAR blockers (after conducting the control experiments in point 2), in the ephrin-B1 knockout mice. The anti-NMDAR antibodies simply remove the receptor from the synapse. This does not address whether the effects are independent of the ionotropic modulation of the channel and should be discussed.</p></disp-quote><p>We agree and think this is a reasonable point. Our toned down discussion of the interaction hopefully will address this comment. We will perform this very sensible experiment when addressing the detailed molecular mechanism underlying the collaboration of NMDAR and EPHRINB/EPHB signaling in regulating callosal innervation patterns in the following project.</p><disp-quote content-type="editor-comment"><p>Revisions expected in follow-up work:</p><p>1) In implicating repellent activity that would restrict commissural axonal projections to the S1 cortex, the evidence for NMDAR via Eph B2 function as repellents for elongating callosal axons is lacking. in vitro experiments demonstrating repellent activity of EphB downstream of NMDAR would be necessary to make this claim. Given the time required to develop and execute such an assay, and the pandemic delays, you could take as long as needed to do this experiment, if you choose to do so.</p></disp-quote><p>We will address it in our follow-up project.</p><disp-quote content-type="editor-comment"><p>2) Reviewers 4 and 5 point out that these pathways could be involved in refinement and pruning of axons: Reviewer 5 raises the possibility that in the mutants, axons are stabilized, to result in extra numbers of callosal neurons. NMDAR could thus be responsible for repulsion during refinement. Reviewer 4's comments on EphBs interacting with excitatory synapse development could play into this explanation. More high-resolution analysis of the impact of your manipulations on axonal branching would address the other reviewers' questions regarding whether the changes see are due defects in branching and/or refinement. This aspect as in the in vitro experiments require additional experiments which could understandably not be possible at this time.</p></disp-quote><p>Thank you for your kindly considerations. We appreciate it. We have discussed all the possibilities raised by reviewers 4 and 5 in our last part of Discussion -“the refinement of callosal innervation pattern”. As for the high-resolution of individual axon branch raised by reviewer 3, we do appreciate the advice and have applied sparse labelling of axon branch in another project when addressing the effect of patient-derived anti-NMDAR autoantibodies on callosal innervation pattern in S1. We are also planning to sparsely label neurons in vivo when addressing the detailed molecular mechanism underlying the collaboration of NMDAR and EPHRINB/EPHB signaling in regulating callosal innervation patterns in the follow-up project. We do hope we can contribute more to the field in these follow up studies.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Revisions:</p><p>The rebuttal letter was difficult to follow. It was not clear where in the manuscript some of the changes were made. Figures were not labelled and main figures were mixed with supplementary figures. However, the following points appear not to have been addressed adequately:</p><p>1) In response to the criticism of overstating the 30% reduction in EphB2 protein expression in the Grin1 CKOs, the authors have provided images showing EphB2 immunofluorescence in Emx1Cre;Grin1fl/fl;tdTomato mice (Figure 8—figure supplement 2). While the pictures in this new figure suggest loss of EphB2 IF in Tom+;Grin1 cKO cells, but not in Tom+;control cells, the results should be quantified. Presenting images without quantification is not convincing. Please quantify and add the results to the paper.</p></disp-quote><p>We have quantified the fluorescence density of EPHB2 immunostaining for each cell. See the Figure 8—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>2) Please address the following points that were raised in the previous critique and appear not to have been answered:</p><p>a) show images of all controls and experimental groups of Figure 3 in Supplementary data.</p></disp-quote><p>The images of the rest of controls and experimental groups for double in utero electroporation have been added it into manuscript as Figure 3—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>b) Provide better evidence for NR1 protein downregulation in the conditional NR1 knockouts (Figure 1—figure supplement 1).</p></disp-quote><p>In addition to the immunostaining data, we performed western blot of S1 at P8. Compared with control, the protein levels of GluN1 were greatly reduced in <italic>Emx1<sup>cre/+</sup></italic>; <italic>Grin1<sup>fl/fl</sup></italic> mice, see Figure 1—figure supplement 1.</p></body></sub-article></article>